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10 Chapter 1
General Introduction
Preview
Chromosomes in the nucleus of cells contain all the information a living 
organism needs to carry out its life processes. Chromosomes are made up of four 
different nucleotides. These four molecules are comprised of a deoxyribose backbone 
with one of four (adenine (A), cytosine (C), guanine (G), thymine (T)) nitrogenous 
bases attached. Different combinations of these four bases make up genes, which 
encode proteins, the building blocks required to “run” a cell. Each human cell 
contains about 6 billion base-pairs, which equals about 2 meters in length. This poses 
two problems: 1) How does two meters of DNA fit in a 5-20 micrometer (a millionth 
of a meter) large nucleus? 2) If all cells have the same material, how does the one cell 
becomes muscle, whereas another cell constitutes an eyelash? The answer, which also 
happened to be the subject of my thesis, is chromatin.
Chromatin
The fundamental unit of chromatin is the nucleosome. Nucleosomes constitute 
the basic unit of chromatin. One nucleosome is made up of 8 histone proteins, two 
copies of each H2A, H2B, H3 and H4, around which are wrapped 147 base pairs of 
DNA, in 1 3/4 left-handed superhelical turns (Finch et al., 1977). In mild 
physiological conditions, histone H3 and H4 form a tetramer that lays at the center of 
the nucleosome with a H2A and H2B dimer at either side (Klug et al., 1980; Arends 
et al., 1991).
The nucleosome plus the fifth histone H1, has been termed the chromatosome 
(for a review see Kornberg, 1999). Only one copy of histone H1 associates with the 
nucleosome and its association is not required for its constitution (Kornberg 1974). 
Binding of H1 to both the major groove of the nucleosome dyad and the minor groove 
of the linker DNA protects another 20bp of DNA (beyond the core particles 147bp) 
against micrococcal nuclease digestion (Noll and Kornberg 1977; Simpson 1978). 
The linker DNA is the “free” DNA of variable length between two nucleosomes 
(Spadafora et al., 1976). Based on the formation of what has been called 
“superstructures” upon addition of H1 to the nucleosome, H1 is believed to stabilize
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the nucleosome and to facilitate the formation of higher order chromatin structures 
(Thoma et al., 1979; Ramakrishnan et al., 1997; Bednar et al., 1998).
Higher order chromatin structures
In cells chromatin comes in two varieties, euchromatin and heterochromatin. 
Euchromatin is considered an open chromatin structure, whereas heterochromatin 
represents a highly condensed inaccessible state. Both states can be defined by the 
presence of distinct chromatin interacting proteins and posttranslational modifications 
(PTMs) (for a review see Huisinga et al., 2006). Euchromatin is also regarded as 
active chromatin with most genes and regulatory regions found in euchromatic 
regions. Heterochromatin is characteristic of gene-poor regions such as telomeres and 
centromeres. One can visualize heterochromatin by its distinctive bright staining with 
interchelating dyes such as DAPI, or by its high electron density with electron 
microscopy. The structure of heterochromatin is believed to be packaged in a 
compact regular 30nm fiber (see below) whereas euchromatin has a more 
discontinues nature as judged by its slower sedimentation speed in sucrose gradients 
(Gilbert and Allan, 2001).
Wrapping DNA in nucleosomes is the first degree of compaction. The second 
step in chromatin condensation is the less characterized 30nm fiber formation. The 
30nm fiber is composed of a tandom array of nucleosomes folded in a condensed 
higher order structure (Gilbert and Rasahoye, 2005). Formation of the fiber is 
believed to involve stabilization of the linker histone H1 and the unstructured N- 
terminal tails that are found to stick out from the nucleosome particle (Luger et al., 
1997). An interaction has been observed between the N-terminal tail of histone H4 
with the flat face surface of the H2A-H2B histone dimer of an adjacent nucleosome, 
suggestive of a role of this tail in across nucleosome higher-order chromatin 
formation (Schwartz et al., 1996; Luger et al.,1997). Interestingly, in line with this 
observation, fully compacted chromatin fibers can be obtained with any of the histone 
tails deleted except for the histone H4 N-terminus. More specifically the interaction is 
mediated by an interaction of the positively charged lysine-rich residues 14-19 with 
negatively charged acidic residues on the H2A-H2B dimer coined the “acidic patch” 
(Luger et al., 1997; Suto et al., 2000; Dorigo et al., 2003). The importance of this
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interaction was further highlighted by the finding that eukaryotic cells have devised a 
way to change the nature of the acidic patch, by the incorporation of the histone 
variants H2A.Z and H2ABbd (Bar body deficient). H2A.Z increases, whereas 
H2Abbd reduces the acidic character of the acidic patch thereby respectively 
stabilizing and destabilizing the inter-nucleosome interactions (Clakson et al., 1999; 
Chatwick and Willard 2001 and discussed below). As the N-terminal histone tails are 
susceptible to a wide range of covalent PTMs, another way of changing this 
interaction is by neutralization of the positive charge on the H4 N-tail by acetylation 
(discussed below).
Normally interphase cellular chromatin is found as a 30nm fiber (Langmore 
and Schutt, 1980), Originally the histone linker H1 was placed on the inside of the 
30nm fiber with the linker DNA connecting two consecutive nucleosomes within the 
same stack. Per turn 6-8 nucleosomes coil around a central cavity constituting the 
superhelix. The formation of such a superhelix is termed a one-start helix (Widom 
and Klug, 1985). In contrast, in the two-start model the linker DNA is found on the 
outside of the superhelix connecting nucleosomes of consecutive stacks (Woodcock et 
al., 1984). Recently, an elegant study showed that most likely the 30nm fiber forms a 
two-step helix (Dorigo et al., 2004). The authors use the recently identified interaction 
between the acidic patch and the histone H4 tail to select a pair of cystein- 
replacement mutants that would allow stabilization (by di-sulfite bridges) of the 30nm 
fiber. Such a fiber was prone to digestion by a specific restriction enzyme at a site 
present in the linker DNA, showing that the linker-DNA is found on the outside of the 
superhelix. Moreover, restriction of the linker DNA of a 10 or 12 nucleosomal repeats 
resulted in two products of 5 or 6 nucleosomes respectively, explanatory of a two step 
model with stacks formed by disulfite cross-links and linker DNA connecting 
nucleosomes of two adjacent stacks (Dorigo et al., 2004).
Although at low-angle-X-ray diffraction most of the chromatin appears as 
30nm fibers, larger structures of 60-130nm fibers have also been observed by EM. 
These structures, (termed “chromonema”) are actual fibers most probably comprised 
of higher order compaction of 30nm fibers (Belmont and Bruce, 1994). The authors 
estimate that the formation of these “chromonema” results in a 160-1000 compaction. 
Maximum compaction the two meters of DNA (in interphase cells) thus will result in 
2000^m of “chromonema” to fit in a 2-20^m small nucleus.
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Figure 1. Different structural levels of chromatin organization.
Epigenetics
Since all cells carry the same genetic material, how then can an organism 
create such a diversity of cell types? The genome carries all necessary information to 
provide variability, but is not directly responsible for creating this diversity of cell 
types. DNA compacted in more or less condensed chromatin structures, occludes or 
allows binding DNA regulatory proteins to their template. And although DNA 
sequences are involved to some extent in determining nucleosome depositing (for a 
review see Rando and Ahmad, 2007) and higher order chromatin formation (for a 
review see Gilbert et al., 2005), de novo heterochromatin formation on sites normally 
devoid of heterochromatin shows that DNA sequences do not dictate the chromatin it 
is wrapped in. For example, although centromeres contain specific repeat sequences 
(a-satellite repeats) that are believed to facilitate constitutive (meaning obligatory 
silenced as opposed to faculatively silenced) heterochromatin formation (Gilbert et 
al., 2004), these sequences are not conserved in higher eukaryotes (Keith and 
Fitzgerald-Hayes, 2000) and some centromeres are formed on sites devoid of a  - 
satellite repeats (Du Sart et al., 1997). Also new centromeres (neocentromeres)
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generally form in regions that do not contain any a-satellite repeats (Du Sart et al., 
1997). In order to understand gene regulation, it is therefore of great importance to 
decipher the exact influence chromatin has on gene-regulation and the factors 
involved in changing the chromatin structure. Epigenetics is the field that studies such 
phenomena. The term is a conjunction of “epigenesis” (morphogenesis, 
development) and “genetics”, originally used to collectively describe all the events an 
organism undergoes from the fertilized zygote to the mature organism (Waddington, 
1951). Nowadays, the term “epigenetics” refers to features such as chromatin and 
DNA modifications that are stable over rounds of cell divisions but do not involve 
changes in the underlying DNA sequence of the organism (for a review see, Bird, 
2007). As my thesis deals with the epigenetics of chromatin and not with DNA 
modifications the focus will be solely on the inheritable changes the chromatin 
structure can pose on the genome. Several such epigenetic mechanisms are discussed 
below.
Remodeling chromatin
As described above, the nucleosome serves to compact DNA in order to fit in 
the nucleus, but this compaction also blocks the transcription machinery from reading 
the genetic material. Nucleosomes occlude transcription factor binding to promoters 
and hinders the polymerase as it travels along its template (for a review see, Li et al., 
2007). Transcribing genes were shown to be assembled in nucleosomes (Lacy and 
Axel, 1975), the question is, how does the transcription machinery overcome this 
physical obstacle? There are a number of different ways of changing the nucleosome- 
DNA interaction known to date that involve, nucleosome assembly/disassembly, 
ATP-dependent remodeling, replication independent incorporation of histone variants 
and post transcriptional modifications of the histones. Each of these mechanisms will 
be separately discussed in the sections below.
Nucleosome assembly/disassembly
Transcription of a gene involves four steps: initiation, promoter escape, 
elongation and termination (for a review see, Svejstrup, 2004). The whole procedure
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is a complex sequence of events that involves a multitude of proteins or protein 
complexes that are involved in distinct steps (often more then one step) of the process 
(Saunders et al., 2006). Where most active promoters are cleared of nucleosomes, the 
body of the gene is not (Lee et al., 2004). The rate of Polymerase II transcription in in 
vitro transcription assays, is severely slowed down on a chromatinized template as 
compared to naked DNA (Kireeva et al., 2002). The transcription rate can be 
increased by transcription in a high salt buffer that destabilizes the nucleosomes 
(Kireeva et al., 2002). Thus, in order to allow Pol II transcription through 
nucleosomes at least partial relaxation of the nucleosome structure is required. On 
mechanism, which helps achieve this relaxation , is nucleosome disassembly.
Nucleosomes are assembled during DNA replication in a process facilitated by 
histone chaperones (for a review see, Polo and Almouzni, 2006). Nucleosome 
assembly at replication is a step-wise process that involves different chaperons. CAF1 
and/or Asf1 facilitate to deposition of H3/H4 tetramers, whereas Nap1 adds 
H2A/H2B at a later step to build the octasomes (for a review see, Zlatanove et al., 
2007). Likewise, chaperones are also believed to be involved in nucleosome 
disassembly and reassembly in processes such as, DNA repair, recombination, and 
transcription (Polo and Almouzni, 2006).
At transcribing genes, 95% of the H2A/H2B dimers and only 5% of the 
H3/H4 tetramer is exchanged, suggesting that the Pol II complex is able to transcribe 
through the H3/H4 tetramer (Thiriet and Hayes 2005). Another study suggests that 
only 1 H2A/H2B dimer is displaced, which would result in transcription through a 
hexasome (Kireeva et al., 2002). Nucleosome assembly factors normally display 
preference for the histones they displace and also for the assembly step they are 
involved in (Polo and Almouzni, 2006). For example, Asf1 and FACT are both 
involved in disassembly and assembly of H3/H4 and H2A/H2B respectively. 
Interestingly, the disassembly of H2A/H2B by NAP1 has been described to facilitate 
transcription factor binding (Walter et al., 1995). Spt6 facilitates chromatin assembly 
behind the elongating polymerase (Kaplan et al., 2003). That reassembly behind the 
elongating polymerase is equally important as paving the way in front of Polymerase, 
is illustrated by a loss of Spt6 in yeast. Loss of Spt6 results in faulty transcription 
initiation from cryptic promoters, a process known to be detrimental to normal 
transcription (Kaplan et al., 2003). Moreover in another study, the loss of Spt6
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allowed transcription to occur even in the absence of activating transcription factors, 
suggestive of an important role for histone reassembly in shutting off transcription 
(Adkins and Tyler 2006).
ATP-dependent nucleosome remodeling
Although active promoters are generally cleared from nucleosomes, 
throughout the cell cycle, nucleosome occupancy at promoters fluctuates with 
maximal depletion correlating with maximal expression levels (Hogan et al., 2006). 
This result argues that although the genome might encode favorable/repressive 
nucleosome positions that allow certain region such as promoters and regulatory 
regions to be free of nucleosomes (Segal et al., 2006; Ioshikhes et al., 2006), in 
repressive conditions, nucleosomes can be moved over unfavorable sequences. 
Illustrative of such a situation is a study where the in vitro nucleosome occupancy on 
the PHO5  and PH O 8  promoters is reconstituted in the presence or absence of 
Drosophila extracts. The favorable position of nucleosomes on naked DNA does not 
correspond to the native situation recapitulated by assembly in the Drosophila extract, 
showing that besides the DNA sequence, additional factors are involved in 
nucleosome positioning (Korber et al., 2006). One such an additional factor is Isw2 in 
S.cerevisiae. This enzyme has been shown to move nucleosomes against the encoded 
favorable position in order to block transcription. In the absence of Isw2 the 
nucleosomes move back and consequently allow transcription to occur (Whitehouse 
and Tsukiyama 2006).
Moving nucleosomes along the DNA is a feature of ATP-dependent chromatin 
remodeling enzymes that are highly conserved proteins that belong to the swi2/snf2 
helicase superfamily of ATP-ases. These proteins can be sub-dived in four families 
based on sequence similarity of their ATP-ase domains these are: SWI2, ISWI, 
Mi2/CHD and INO80 (Tsukiyama 2002; Armstrong 2007). The mechanism by which 
these enzymes exert their function is believed to involve sliding (in a wave like 
movement) of the nucleosomes along the DNA template (Flaus and Owen-Hughes 
2004; Zhang et al., 2006). These enzymes are either involved in activation or 
repression on the level of both transcription initiation and elongation (Armstrong 
2007). Although their activity is normally well defined, different activities have been
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observed for the same enzyme dependent on its association with different complexes 
(for a review see, Langst and Becker (2001). For example, the ATPase remodeling 
enzyme ISWI is associated with three different complexes, ACF, CHRAC and NURF. 
ACF and CHRAC are repressive complexes that are involved in regular spacing of 
nucleosomes on a DNA template in vivo, whereas NURF disrupts regular spaced 
nucleosomal arrays (Langst and Becker (2001).
Histone variants
An additional way to alter the chromatin structure is the exchange of 
conventional histones with histone variants. Several different histone variants have 
been discovered with the exception of histone H4. These variants are involved in 
many different cellular functions ranging from transcriptional activation, repression 
and memory to DNA damage and centromere formation. Different from conventional 
histones, histone variants are expressed in both a replication dependent and 
independent manner and are usually encoded by only one gene (for a review see, 
Bernstein and Hake 2006).
Among the most well known histone variants is H2A.X, required for the 
formation of DNA-damage induced foci. H2A.X functionally differs from H2A in the 
presence of a unique SQ motif at its C-terminal tail. The serine 139 (S139) is 
phosphorylated by the ATM kinase. This phosphorylation results in the accumulation 
of DNA-damage response proteins at the site of the DNA double-stranded break (for 
a review see, Redon et al., 2002). H2A.X has also a role in meiotic silencing of the 
XY body in the male germline and maintenance of genomic stability (Celeste et al., 
2002; Celeste et al., 2003; Fernandez-Capetillo et al., 2003).
Another H2A variant with a very specific function is macro-H2A. Macro-H2A 
is localized to the female inactive X chromosomes (Xi) (Chakravarthy and Luger, 
2006). Different versions exists of this variant that are all found to localize to the Xi 
(Chatwick and Willard 2001). Interestingly only macroH2A version 1.1 binds with 
high affinity to O-acetyl ADP-ribose a molecule also involved in telomere silencing 
(Liou et al., 2000; Kustatscher et al., 2005) although the function of O-acetyl ADP- 
ribose binding remains elusive. The mechanism by which macroH2A exert its 
repressive function is poorly understood, although repression of transcription by steric
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hindrance of the relatively large macro domain seems most plausible (Doyen et al., 
2006) since macroH2A has been shown in vitro to be refractory to SWI/SNF 
remodeling (Angelov et al., 2003).
Interestingly another histone variant H3.3 is enriched on the hyper active male 
X- chromosome in Drosophila, although different from macroH2A, this enrichment is 
most likely not the cause but the consequence of hyper-activity. Canonical H3 is 
namely replaced in a replication independent manner by H3.3 during transcription 
(Mito et al., 2005). H3.3 is especially interesting since it is the only histone variant 
that is conserved from yeast to humans (Ahmed and Henikoff 2002). Also, its 
deposition into transcriptionally active loci is conserved, but its role in transcription 
remains speculative (Ahmed and Henikoff 2002b; Janicki et al., 2004).
The role that most histone variants play in histone biology at present remains 
uncertain. An attractive hypothesis is that histone variants could epigenetically mark 
transcriptional history of genes, as is proposed for H2A.Z and could be the case for 
H3.3 (Brickner et al., 2007). H2A.Z incorparation in the promoter of the INO1 and 
GAL1 genes in yeast, confers transcriptional memory that allows them to more 
rapidly respond upon a next round of transcriptional activation (Brickner et al., 2007). 
In the case of H2A.Z this property most probably involves the formation of a 
nucleosome structure that is less stable and could be easier to clear off promoters 
(Suto et al., 2000; Ramaswamy et al., 2005).
Post Translational Modifications of histones
Initially DNA was disregarded as the carrier of genetic information due to the 
simple nature of its molecule and its underrepresentation in the cell as opposed to 
proteins (Felsenfeld, 2007). Histones for a long time were believed to be the heritable 
material not at the least because of their apparent variety (Stedman, 1950 and for a 
review, Kornberg and Lorch, 1999). Nowadays we know that DNA (the genome) is 
the heritable material with heritable states preserved by differences in chromatin 
structure (the epigenome). Where the variety in histones turned out to be most likely 
due to degradation (kornberg and Lorch, 1999), we know now that despite of the 
presence of only four canonical histones, endless variations are possibly with the 
exchange of histone variants and especially with a repertoire of over 30 histone PTMs
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(for a review see, Margueron et al., 2005). At present, the PTMs known are: 
acetylation, methylation, phosphorylation, ubiquitination, sumulation, ADP- 
ribosylation and proline isomerization (for review see, Millar and Grunstein 2006).
Most modifications localize to the amino-terminal tail (N-tail) and few 
localize to the carboxy-tail (C-tail) or the globular domains of histones. All these 
modifications are reversible and there are numerous enzymes that establish these 
modifications as well as enzymes that remove these modifications (Millar and 
Grunstein 2006). As the focus in this thesis is mainly on histone acetylation, other 
modifications are only briefly discussed.
It was already noted more than 40 years ago that histone acetylation is 
associated with transcriptional activity (Allfrey et al., 1964). The way histone 
acetylation exerts its function on transcription is believed to involve at least two non- 
mutually exclusive mechanisms. Indirectly, PTMs can create specific platform that 
are recognized by chromatin binding proteins to promote distinct cellular events or 
directly by changing electrostatic interaction between the histones and the DNA. Only 
histone acetylation, through the neutralization of positive charge, and phosporylation 
by addition of negative charge, are likely candidates to change the electrostatic 
interactions between chromatin and DNA. Both mechanisms of altering chromatin 
structure are discussed below.
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Figure 2. Different post-translational modifications of histones. (Figure by Mikko 
Taipale).
The histone code
Histone tail modifications are believed to establish specific “codes” that can 
be read and translated into different cellular outputs (Strahl and Allis, 2000; Jenuwein 
and Allis, 2001). The histone code hypothesis states that (1) specific binding modules 
exists that bind histone tail modifications and (2) that these modifications are 
interdependent and create various combinations on any of the nucleosomes (3) certain 
combinations of histone modification have definable and predictable outcomes.
Recognition of specific PTMs by chromosomal proteins is based on binding of 
certain domains such as the chromodomain, WD40 domain, tudor domain, MBT 
domain and the bromodomain to PTMs (Millar and Grundstein, 2006). Only the 
bromodomain is involved in the binding of acetylated lysine, all other domains are 
involved in binding of methylated residues.
Conversely a non-modified histone tail could also serve as a binding site, such 
that specific modifications inhibit binding of an effecter protein. As an example 
deacetylated H4K16 is the substrate for the hetererochromatin protein Sir3 and the
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ATP-dependent chromatin-remodeling enzyme ISWI (Hecht et al., 1996; Corona et 
al., 2002).
The “histone code hypothesis” predicts that certain single or combinatorial 
marks have distinct cellular outcomes. The classical example was binding of 
heterochomatin-like protein 1 (HP1) to methyl H3K9 by its chromodomain to 
promote heterochromatin formation (Bannister et al., 2001; Lachner et al., 2001). 
Many more of such examples thereafter were discovered that are consistent with this 
initial observation (Millar and Grundstein 2006; Berger, 2007).
However, some histone marks are associated with both repressor and activator 
complexes, severely complicating the predictive outcome of certain histone 
modifications. For example, although di or tri methylation of histone H3 at lysine 4 is 
generally found associated with actively transcribed genes (Krogan et al., 2002; Ng et 
al., 2003; Santos-Rosa et al., 2002; Schneider et al., 2004), the mark is also the target 
site for a histone deacetylase (HDAC) containing Sin3-HDAC1 repressive complex 
that is activated upon DNA damage (Shi et al., 2006) and the CoR co-repressor 
complex that binds through its tandom tudor domain of JMJD2A to both H3K4me3 
and H4K20me3 (Huang et al., 2006).
Similarly, histone acetylation is generally associated with active transcription 
(Sewack et al., 2001; Schuebeler et al., 2004, Roh et al., 2005). Therefore 
deacetylation is logically expected to correlate with transcriptional repressive states. 
Although generally true, recent data also show that a number of HDACs, such as 
Hos2 and Rpd3 also associate with active genes. Both HDACs associate with the 
same portion of genes but do so at different transcriptional stages (Wang et al., 2002; 
De nadal et al., 2004).
Moreover, not only are the same marks recognized by different complexes 
with different transcription implications, also PTMs thus far believed to have a 
transcriptional repressive role are found associated with active transcription. H3K9 
(tri) methyl and HP1 are also found preferentially associated on the ORFs (open 
reading frame) of active genes (Vakoc et al., 2005). A result strikingly similar to the 
H3K36 pattern, possibly reflecting a similar role for H3K9me as that attributed to 
H3K36 in preventing cryptic initiation by reforming the chromatin structure in the 
wake of active transcription (Carrozza et al., 2005). This observation might also 
explain the intuitive contradictory action of JMJD2A as discussed above. Intriguingly,
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in embryonic stem cells large domains of both high H3K4me3 (active mark) and 
H3K27me3 (inactive mark) levels have been found, again two marks that are believed 
to have opposing effects on transcription (Bernstein et al., 2006). As these marks are 
found on genes involved in development, they might establish transcriptional 
potential.
A similar role might explain the opposing roles attributed to H4K16 
acetylation. H4K16Ac is required for preventing heterochromatin spreading at 
telomeres (Kimura et al., 2002; Suka et al., 2002) and is involved in the hyper­
activation of the male X-chromosome in Drosophila (for a review see, Mendjan and 
Akhtar, 2006). In line with an activating role for H4K16Ac in transcription, in yeast, 
on histone H4, only H4K16Ac has a direct effect on transcription whereas all other 
acetylation marks have an additive effect (Dion et al., 2005). Surprisingly therefore, is 
the finding that H4K16Ac in yeast negatively correlates with transcription (Kurdistani 
et al., 2004). Since one the early events in transcription involves histone acetylation, 
H4K16Ac might establish transcription potential as it has been suggested previously 
(Anguita et al., 2001).
Therefore, although it has been very convincible shown over the past decade 
that histone modifications can target specific effector proteins and that certain 
modifications, alone or in combination, are generally correlated with distinct 
chromatin structures and transcriptional events, in order to “read and interpret the 
code” one needs to consider the regulatory context in order to understand the 
biological meaning of “the code” (Berger, 2007).
PTMs and chromatin structure
Although most acetylation is found in promoters and regulatory regions 
(Bernstein et al., 2005), a second means of acetylation-mediated transcriptional 
control has been correlated with broad acetylation (>100kb) that spans single genes or 
entire gene clusters, such as the growth hormone or ß globin locus (Elefant et al., 
2000; Kinura et al., 2004). These domains are generally gene-dense and sensitive to 
DNaseI digestion and are therefore thought to be in an open chromatin conformation. 
In this case acetylation of histone tails is believed to neutralize the charge of the basic 
histone H3/H4 tails and thereby disrupt the interaction with the negatively charged
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DNA (Grundstein, 1997). Hyper-acetylation of histone tails has been shown to; 
weaken nucleosome stability (Brower-Toland al., 2005; Dunker et al., 2001), increase 
accessibility of chromatin fibers (Anderson and Widom, 2001; Gorisch et al., 2005), 
facilitate the H2A/H2B exchange during transcription elongation (Morales and 
Richard-Foy, 2000) increase RNA polymerase II elongation rates and reduce 
stuttering (Protacio et al., 2000).
As mentioned above, fully compacted chromatin fibers can be obtained with 
any of the histone tails deleted except for the histone H4 N-terminus. Histone H4 
thus, is the most likely candidate to pose any major structural change upon the 
chromatin fiber. H4K16Ac specifically has been shown to cause an increase in the a- 
helical content of Histone H4, and to prevent 30nm chromatin-fiber formation and 
cross fiber interactions (Shogren-Knaak et al., 2006). Possibly as the residues 14-19 
in the histone H4 tail interact with the “acidic patch” formed by the histones 
H2A/H2B (Dorigo et al., 2003; Schalch et al., 2005; Fan et al., 2004) neutralisation of 
the positive charge by acetylation could results in weakening of the nucleosome- 
nucleosome interaction and a destabilization of higher-order chromatin formation. In 
addition, very recently it has been shown that Dot1 the H3K79 methyl-transferase 
(HMT) involved in heterochromatin formation in yeast, requires a charge based 
interaction of an acidic patch in the protein with the residues 17-19 in H4 in order to 
be active as a HMT (Fingerman et al., 2007). Therefore, acetylation might not only 
influence chromatin structure, but also possibly by a similar mechanism poses 
constraints on other histone modifying enzymes with opposing chromatin 
characteristics. As methylation does not change the charge of lysine residues, these 
PTMs are unlikely to have any structural consequences.
Thinking globally: The nuclear architecture
So far in this thesis, I have discussed chromatin as a more or less condensed 
linear template, subject to a diverse set of chromatin modifications that exert their 
function either directly, by electrostatic interaction, or indirectly through effector 
proteins. However, it is becoming extensively clear that the nucleus is built-up of 
subcompartments with distinct transcription activities. It is believed that this 
organization is important to organize and maintain the complexity of the genome.
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Therefore in order to understand the complex process of gene expression, one should 
study a gene of interest or chromatin region in the context of the 3D organization of 
the genome (Gottschling, 2007). As my thesis involves the functional characterization 
of nucleoporins I will focus here on the nuclear periphery.
Originally the nuclear periphery, and especially the nuclear lamina, has been 
shown to act as a docking site for many different repressive complexes (for a review 
see Taddei, 2007). It has long been known through electron microscopy images that 
heterochromatin clusters to the nuclear periphery, and many nuclear processes that 
involve repressive heterochromatin formation, such as telomere clustering and the 
inactive X chromosome in mammals are localized at the nuclear periphery (for review 
see Shaklei et al., 2007).
Heterochromatin extends entirely over the nuclear surface, except for a small 
circular space adjacent to nuclear pore complexes (NPC) (Dwyer and Blobel, 1976). 
This space has long been proposed to serve as a locale where transcription and much 
of the posttranscriptional processes would occur. The NPC in this model serves as a 
3D coordination point in the nucleus for expanded (euchromatin) domains to form 
and simultaneously efficiently “gate” transcripts to the cytoplasm (Blobel, 1985).
The view of the nuclear periphery as a repressive zone has only recently 
experimentally been challenged by the finding that nucleoporins interact with 
“expanded (transcribable) genes (Casolari et al., 2004) and a number of independent 
studies have shown that genes are recruited to the periphery upon transcriptional 
induction (Casolari et al., 2004; Brickner and Walter 2004; Abruzzi et al., 2006; 
Taddei et al., 2006; Cabal et al., 2006; Brickner et al., 2007). The nuclear periphery 
has been proposed to provide an optimal transcriptional niche in which genes are 
confined to 2D lateral movement along the nuclear periphery (Cabal et al., 2006; 
Taddei et al., 2006) functionally similar to proposed role of the locale surrounding the 
NPC (Blobel, 1985).
Gene expression involves the concerted action of a number of processes such 
as, transcription initiation, elongation, termination, pre-mRNA processing, quality 
control and mRNP (messenger ribonucleoprotein particle) assembly and translocation 
to the NPC for export. These events are frequently found to be interconnected, with 
most factors, including export factors, already recruited to genes cotranscriptionally. 
For example the TREX (transcription and export) complex contains factors involved
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in both transcription elongation and mRNA export (Strasser et al., 2002). 
Furthermore, Sus1 (a component of the SAGA histone acetyltransferase complex) is 
not only involved in transcriptional activation, but also associates with the Sac3- 
Thp1-Cdc31 mRNA export complex bound to the NPC by Nup1 (Rodriquez-Navarro 
et al., 2004). Consequently many factors involved in different steps of gene 
expression are also required for anchoring genes to the nuclear periphery (for review 
see Cabal, 2007).
Anchoring of active genes to the NPC could create an “optimal niche” to favor 
the coordination of the different processes occurring at an active gene as in the 
original version of the ‘gene gating’ hypothesis (Blobel, 1985).
Gene anchoring to the nuclear periphery
That genes localize to the nuclear periphery upon activation suggests that the 
periphery confers optimal expression levels. Although this is the prevalent view, there 
are also reports that suggest that genes do not need to be anchored to the periphery in 
order to be optimally expressed.
Cabal et al. show that the expression levels of GAL1 are not affected when the 
association of this gene with the NPC is abrogated by a deletion of Nup1 (Cabal et al., 
2006). Similar data exists on the heat-shock gene HSP104 (Dieppois et al., 2006). 
Also, transcriptional activity is not required to maintain genes on the periphery as the 
INO1 gene has been found to remain peripheral up to 6 generations after transcription 
was turned off (Brickner et al., 2007). It is therefore conceivable that genes are first 
activated and subsequently relocated to the periphery. The periphery might therefore 
not directly be involved in transcription activation but more likely has a regulatory 
function e.g. in maintaining expression levels or to create a platform where the 
multitude on different factors involved in gene expression meet and coordinate 
transcript maturation.
On the other hand, several groups also report that artificial gene induction can 
be accomplished by tethering genes to the NPC (Menon et al., 2005; taddei et al., 
2006, Brickner et al. 2007). Possibly, these genes profit from a reservoir of different 
proteins present in the NPC locale that they otherwise would not encounter. It is 
possible that different nucleoporins play different roles, or even different roles are
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played by the same nucleoporins. For example, nucleoporins are reported to be 
involved in transcriptional memory formation by a process that involves the histone 
variant H2A.Z (as discussed above) and also in boundary formation (Schmit et al.,
2006). Similar to the situation for B-type lamin in Drosophila, nucleoporins could 
also establish large chromosomal domains that creates a protective transcriptionally 
active environment shielded off from heterochromatin spreading from neighboring 
sites (Brown and Silver, 2006). As all studies so far were restricted to yeast it is 
necessary to widen the scope and also focus on higher eukaryotes.
Targeting genes to the NPC by Mlp1 and Mlp2
Two nucleoporins involved in gene anchoring are Mlp1 and Mlp2 
(mammalian TPR, Drosophila Mtor). Mlps are exclusively nuclear and part of the 
nuclear basket (for a review see, Hetzer et al., 2005). In yeast, Mlp1 and Mlp2 where 
found to be non-randomly distributed on the nuclear periphery suggesting that NPC 
exist that do not contain any Mlps (Galy et al., 2000). Non-random distribution of 
nucleoporins and the existence of different constituted NPC could mirror the 
underlying periodic organization of the genome as proposed by Blobel (Blobel, 
1985). In higher eukaryotes however, TPR and Mtor are found evenly distributed 
along the periphery (Cordes et al., 1997; Mendjan et al., 2006). Mlps physically 
associate with a number of different mRNP components and also with the SAGA 
complex (Green et al., 2003; Galy et al., 2004; Vinciquerra et al., 2005). ChIP and 
microarray expression experiments show that Mlps associate with frequently 
transcribed genes with a binding profile across genes with a 3’ bias (Casolari et al., 
2004; Casolari 2005). Interesting in this respect is that the 3 ’UTR was found 
indispensable for the genes translocation to the nuclear-pore (Cabbei et al., 2006; 
Abruzzi et al., 2006). Moreover, binding is RNA sensitive, suggesting Mlps 
association with genes involves the native transcript. Together with Mlps requirement 
for gene-anchoring (Dieppois et al., 2006), these results argue for cotranscriptional 
recruitment of Mlps to genes followed by stabilization or translocation of genes to the 
nuclear periphery.
General Introduction 27
Dosage compensation
Sex determination often involves differentiation of a pair of chromosomes 
such that one sex retains the original two copies (homogametic) whereas in the other 
sex one of the homologous chromosomes degenerates almost completely with only 
the exception of a few sex specific genes (heterogametic). The deleterious effects of 
aneuploidy create the need for a compensatory process that equalizes the gene 
products between the two sexes (Charlesworth, 1996; Nusinow and Panning 2005).
In Drosophila dosage compensation is achieved by a 2-fold up-regulation of 
the single male X chromosome, whereas in Mammals and C.elegans up-regulation 
occurs in both sexes with a reduction of expression in the homogametic sex (for a 
review see, Straub and Becker, 2007; Deng and Disteche, 2007). Although Dosage 
compensation is a common phenomenon for many species, the mechanism has 
evolved independently several times on a relatively short time-scale. Different 
mechanisms have evolved by adopting different proteins or protein complexes. These 
involve a condensing like complex in C.elegans (for a review see, Meyer et al., 2004), 
and the polycomb repressive complexes PRC1 and PRC2 in addition to the histone 
variant macroH2A (for a review see, Heard and Disteche).
M am m a ls Drosoph ilidae C. elegans Birds
Sex
determination
XX/XY X /A  ratio XX/XO ZW/ZZ
Dosage YXnX XY=xx xx=XO ??
compensation X inactivation X  hypertranscription X  repression
Mechanism Polycomb complex MSL complex
Condensins 
Polycomb complex
??
Molecules
Eed/Enx1
BRCA1
MSLs DPYs, SDCs, M IX-1  
MES proteins
??
RNA XIST roX1, roX2 ?? ??
Figure 3. Dosage compensation in different species
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Dosage compensation in Drosophila is accomplished by the male specific 
lethal (MSL) complex, which consists of five male specific lethal proteins (MSL1, 
MSL2, MSL3, MLE and MOF) and two non-coding RNAs (roX1 and roX2). 
(Mendjan and Akhtar, 2006; Straub and becker, 2007. Interestingly, the MSL proteins 
(except for MLE) have no known function outside of fly dosage compensation, 
although the proteins are highly conserved also in species with different dosage 
compensation mechanisms such as mammals (Marin and Baker 1998).
Targeting the dosage compensation complex to the X chromosome
The m olecular mechanism underlying dosage compensation is poorly 
understood. Part of the function of the MSLs is thought to involve the recruitment and 
activation of MOF to the X-chromosome. MOF is a histone acetyltransferase (HAT) 
that unlike most other HATs specifically acetylates lysine 16 of histone H4 
(H4K16Ac), a modification found highly enriched on the male X chromosome (Bone 
et al., 1994). This enrichment on the male X chromosome coincides with the MSLs 
(Bone et al., 1994; Smith et al., 2001).
How the MSL complex distinguishes the X from the autosomes remains a 
mystery despite of extensive research on the subject. Recent high resolution MSL1 
and MSL3 binding profiles revealed interesting insights into MSL targeting to the X 
chromosome. These analyses revealed that MSL1 and MSL3 are targeted primarily to 
actively transcribed genes with an overall enrichment towards the 3 ’ end (Legube et 
al., 2006; Alekseyenko et al., 2006; Gilfillan et al., 2006).
Originally, targeting in D rosophila  was believed to involve binding to a 
limited number of “entry sites” (Kelley et al., 1999). This model emerged from the 
observation that in flies mutant for either, MSL3, MLE or MOF, a heterodimer of 
MSL1 and MSL2 targets a limited number (35-100) of sites on the X chromosome. 
Interestingly, the genes coding for the non-coding RNAs in the MSL complex, rox1 
and rox2  were found to constitute an entry site (for a review see, Mendjan and 
Akhtar, 2006; Straub and Becker, 2007). The nature and function of these sites is very 
poorly understood. They were believed to function as nucleation sites where the MSL 
complex enters, followed by spreading in cis to neighboring lower affinity sites This
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theory was supported by the observation that the MSL complex occasionally spreads 
in cis from ectopically inserted rox genes (Kelley et al., 1999; Kageyama et al., 2001). 
A number of recent studies however, showed that X chromosomal genes are targeted 
in trans in the absence of any entry sites (Demakova et al., 2003; Fagegaltier and 
Baker 2004; Oh et al., 2004), which makes the function of these sites in dosage 
compensation unclear. At present, the MSL complex is assumed to bind to variable 
combinations of several degenerative sequences although their predictive power is 
still very limited (Gilfilian et al., 2006).
Aim of the study
A fundamental question in chromatin biology is how different proteins or 
protein complexes are targeted to the right place at the right time. Considerable 
progress has been made with the discovery of a number of domains that recognize 
specific histone modifications, however, as different complexes recognize the same 
marks, being able to read a certain code is not the whole story. In addition, the great 
majority of global analysis of histone modifications were performed in an 
asynchronously cell population, providing information of only a snapshot of the 
whole picture. As transcription involves the subsequent recruitment of many different 
factors as the polymerase complex moves along the gene, it is important to study 
recruitment of chromatin complexes dynamically in the context of the ongoing 
transcription machinery. In addition, considerable evidence has highlighted the 
importance of studying gene expression not only as a linear chromatin template but 
also globally in the nuclear space.
During my thesis I have studied targeting of the MSL complex in Drosophila 
as a model for general targeting of chromatin complexes. The aim was to study the 
mechanism of targeting from different angles by applying different techniques to 
collectively obtain a better understanding of the process, not only at the local gene 
level but also globally in the nuclear space. Dosage compensation in Drosophila 
provides excellent opportunities to study targeting of chromatin complexes, as the 
MSL complex is targeted to hundreds of genes individually by a process that is 
believed to be mechanistically similar, global analyses have great statistical power to 
uncover underlying principles of targeting. Furthermore the use of Drosophila as a 
model organism provides one with well-developed genetic tools and a detailed
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annotated genome. In the study presented here, I have combined genetics and global 
transcription and binding analyses as well as manipulations by RNA interference 
(RNAi), to gain better understanding of the mechanism underlying targeting of the 
MSL complex to the male X chromosome.
Chapter 2 describes a detailed study on MSL targeting to the two X-linked 
genes, CG3016 and m of using a combination of chromatin immunoprecipitation 
(ChIP) and Immuno-FISH on transgenic flies. We show that MSL target recognition 
requires a combination of transcriptional activity and targeting elements resigning in 
the 3 ’ end of both genes. Transcription is most likely required to expose these 
elements for MSL recognition, as these target elements are necessary but not 
sufficient on themselves to recruit the MSL complex. These results have led us to 
propose a model of cotranscriptional recruitment of the MSL complex to X-linked 
genes based on 3 ’ target elements.
In Chapter 3 we have extended our analysis to a genome-wide scale by 
hybridizing chromatin immunoprecipitated DNA to high-resolution tiling arrays 
(ChIP-on-chip) covering the entire fly genome with a 35bp resolution. We observed 
that on the X chromosome, whereas MSL1 and MSL3 are preferentially associated 
with the 3’end of genes, MOF binding sites display a bimodal distribution, associating 
primarily with promoter-proximal regions and 3’ ends of genes. Different from the 
MSL1 and MSL3 binding profiles that display almost exclusive binding to the X 
chromosome, MOF binds to promoter proximal regions on male autosomes and the 
entire female genome. Binding of MOF to promoter proximal regions is independent 
of the MSL complex on all chromosomes, whereas targeting to the body of dosage 
compensated genes is interdependent between MSL1 and MOF. Binding of MOF to 
autosomes is shown to be associated with cis-regulatory function, as H4K16Ac and 
the transcription levels of a number of genes are affected in MOF-depleted cells. In 
addition, a comparison between the H4K16Ac profiles between genes on the X 
chromosome and the autosomes revealed that the distribution of H4K16Ac is a direct 
reflection of a change in the MOF binding profile.
Finally in Chapter 4 we discuss the biochemical purification of the MOF and 
MSL3 complex and the association of NUP153 and Mtor (two nucleoporins) with the 
MSL complex. We show that both NUP153 and M tor are required for the 
characteristic localization of MSLs to the male X chromosome in male tissue culture
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cells. RNAi mediated depletion of these nucleoporins results in a two-fold 
downregulation of a number of dosage compensated genes, whereas autosomal genes 
and genes that are not dosage com pensated rem ain m ostly unaffected. 
Downregulation of these genes is the result of a loss of dosage compensation, since 
the same genes in a female cell line upon depletion of NUP153 and Mtor remain 
unaffected. These results reveal a novel physical and functional interaction of two 
nuclear pore components with the MSL complex.
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Co-transcriptional recruitment of the dosage compensation complex 
to X-linked target genes
Jop Kind and Asifa Akhtar 
Abstract
Dosage compensation is a process required to balance the expression of X-linked 
genes between males and females. In Drosophila this is achieved by targeting the 
dosage compensation complex or the MSL complex to the male X chromosome. In 
order to study the mechanism of targeting, we have studied two X chromosomal 
genes, m of and CG3016, using chromatin immunoprecipitation as well as immuno- 
FISH analysis on transgenic flies. We show that MSL complex recruitment requires 
the genes to be in a transcriptionally active state. MSL complex recruitment is 
reversible because blocking transcription severely reduces MSL binding to its target 
genes. Furthermore, targeting cues are found towards the 3’ end of the gene and 
depend on the passage of the transcription machinery through the gene, whereby the 
type of promoter and the direction of transcription are dispensable. We propose a 
model of dynamic MSL complex binding to active genes based on exposed DNA 
target elements.
Introduction
Sex determination often involves differentiation of a pair of chromosomes 
such that one sex retains the original two copies (homogametic), whereas in the other 
sex one of the homologous chromosomes degenerates almost completely with only 
the exception of a few sex specific genes (heterogametic). The deleterious effects of 
aneuploidy creates the need for a compensatory process that equalizes the gene 
products between the two sexes (Charlesworth and Charlesworth 2005). In 
Drosophila, dosage compensation occurs by increasing transcription of most genes on 
the single male X chromosome to compensate for transcription of both X 
chromosomes in females. Genetic studies have identified five male specific lethal 
(MSL) genes, m sll, msl2, msl3, males absent on the first (mof) and maleless (mle), 
that are important for the regulation of dosage compensation. The products of these 
genes (collectively referred to as MSL genes), as well as two non-coding RNAs (roX1
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and roX2) assemble in a large complex called the dosage compensation complex 
(DCC) or the MSL complex, which is targeted to hundreds of sites on the male X 
chromosome (Lucchesi et al. 2005; Mendjan and Akhtar 2006; Straub and Becker
2007).
One of the most intriguing features of the MSL complex is its ability to 
recognize its targets on the male X chromosome. Studies that involved P-element 
mediated insertions of X chromosomal genes on autosomes and X-autosome 
translocations have shown that most X linked genes were still targeted when inserted 
on an autosome. In contrast, autosomal genes translocated to the X remained 
untargeted (Fagegaltier and Baker 2004; Oh et al. 2004). Targeting therefore most 
likely happens on genes individually and may not require the presence of 35-40 so 
called “entry sites” (Kelley et al. 1999).
Recent chromatin profiling studies, have confirmed the preference of the MSL 
complex for individual genes. The MSLs were found to bind locally to genes with 
MSL occupancy predominantly at the 3 ’ of genes (Alekseyenko et al. 2006; Gilfillan 
et al. 2006; Legube et al. 2006). Moreover the affinity of MSL1 for its targets 
correlates with its dosage compensated state (Gilfillan et al. 2006; Legube et al. 
2006). Therefore the affinity of the MSL complex might have evolved concurrent 
with the need for dosage compensation of its targets. This is in agreement with the 
findings that those genes strongly bound by MSL1 are more generally essential genes 
(Gilfillan et al. 2006).
Despite the large number of MSL targets recently identified by chromatin profiling 
studies, a universal targeting sequence motif has not been identified for the MSL 
complex. Also the proposal that the MSL complex simply targets those genes on the 
X that are transcriptionally active does not seem to universally apply since there are 
many genes on the X that are transcriptionally active, but not bound by the MSLs 
(Alekseyenko et al. 2006; Gilfillan et al. 2006; Legube et al. 2006). It seems 
conceivable that transcription is a prerequisite for target recognition but not sufficient 
by itself, because most target genes are transcribed and those few genes that show 
differential expression are only bound when the gene is active (Alekseyenko et al. 
2006). Although no universal targeting sequence has been found, a number of short 
degenerative sequences with some predictive power have been identified (Dahlsveen 
et al. 2006). It is therefore possible that these degenerative sequences are only
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exposed when the gene is active and the chromatin is present in an open 
conformation.
An assumption of the above hypothesis would be the ability of the MSL 
complex to associates with genes only while transcription is ongoing presumably at 
the stage of transcriptional elongation. Therefore targeting cues may reside in the 
body of the gene as opposed to the original reports of upstream enhancer sequences 
present in dosage compensated genes (for review see (Baker et al. 1994)), but in 
agreement with recent MSL profiling studies (Smith 2001; Alekseyenko et al. 2006; 
Gilfillan et al. 2006; Legube et al. 2006).
In order to gain better insights into targeting mechanism, we studied two 
neighbouring genes CG3016 and m o f for their targeting properties as they recently 
have shown to be targeted by the MSL complex in genome-wide analysis (Gilfillan et 
al. 2006; Legube et al. 2006). The m of gene encodes for the histone acetyltransferase 
in the MSL complex that specifically acetylates lysine 16 of histone H4 (H4K16). 
Apart from the two roX  RNA encoding genes, m o f is the only other known MSL 
member whose gene is located on the X chromosome. Interestingly, we find that 
transcriptional activation is required for targeting of the MSL complex and that 
polymerase passage through the gene is a prerequisite for target recognition. We also 
show that this is true for most genes on the X chromosome as blocking transcription 
by aam anitin treatment, greatly reduced binding of the MSL complex to X 
chromosomal genes. Finally we show that in addition to transcription, targeting to the 
m of and CG3016 genes most likely is a combination of degenerative DNA sequences 
towards the 3 ’end of these genes only to be recognized when the gene is 
transcriptionally active.
Results 
MSL proteins are enriched on the region spanning the mof and CG3016 genes
In order to precisely map the binding pattern of MSLs on the m of and CG3016 
loci we performed chromatin immunoprecipitation (ChIP) experiments in Drosophila 
Schneider cells (SL-2) using specific antibodies directed against MSL1, MSL3 and 
MOF. SL-2 cells are a male 16 hr embryonic cell line with a MSL binding pattern 
closely reflecting that of late stage embryos (Alekseyenko et al. 2006). The
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immunoprecipitated material was analyzed by quantitative realtime PCR (Q-PCR) 
and presented as the percentage recovery compared to input DNA (Figure 1A). The 
roX2 high affinity site, which served as a positive control showed highly enriched 
MSL binding (lane 15) as opposed to gapdh (located on chromosome 2R) (lane 14) 
and the run t gene (located on the X chromosome) (lane 13), but is dosage 
compensated in an MSL independent fashion (Gergen 1987; Smith et al. 2001). 
Binding was enriched on the body of the gene for both CG3016 and m o f for all the 
three MSL proteins tested (Figure 1, lanes 1-12). Unlike MSL1 and MSL3, there is 
also considerable binding of MOF to the promoter regions (see lanes 1 and 5). 
Whether the binding of MOF to promoters reflects its general binding pattern on a 
genome wide scale remains to be tested.
We next wished to test if a large genomic fragment including m of and most of 
C G 3016  was able to target the MSL complex ectopically when inserted on an 
autosomal location by means of P-element mediated transformation. As is shown in 
Figure 1B this 6.7kb fragment (m o f6J) showed robust MSL1 recruitment visualized 
by staining with an MSL1 antibody in combination with fluorescence in situ 
hybridization (immuno-FISH) to visualize the location of the transgene (see Materials 
and Methods). The presence of MSL1 and the direct visualization of targeting on 
polytene chromosomes enabled further detailed analysis of the nature of targeting to 
this locus.
Taken together, these results show that MSL1 protein is enriched on m of and 
CG3016 genes and that this region is able to recruit MSL complex autonomously on 
an autosomal location.
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Figure 1. Transcriptional dependent recruitment of MSL1 to the mof gene.
(A) ChIP in SL-2 cells on the CG3016 and mof genes with antibodies directed 
against MSL1, MSL3 and MOF. Levels of enrichment are determined by Q-PCR and 
depicted as the percentage recovery of input DNA. Position of the primer pairs is 
schematically shown by green arrows. (B, C, D) MSL1 immunostaining (green) in 
combination with DNA-FISH (red) directed against the mini-white gene of a polytene 
chromosome carrying an autosomal 6.7kb P-element insertion encompassing mof and 
the coding region of CG3016 (B), an autosomal P-element insertion of mof with its 
endogenous promoter (C) or without its endogenous promoter (D). Recruitment of 
MSL1 to the transgenes is indicated by an arrow. Position of the endogenous mof 
gene is shown by an asterisk. DNA was stained with Hoechst 322 (blue).
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MSL1 is recruited to the mof gene in a transcription dependent manner
In order to study targeting to individual genes, we first generated transgenic 
flies carrying the m of gene with its endogenous promoter sequences (mof35). The m of 
gene showed ectopic MSL1 recruitment in almost all independent lines that were 
observed (Figure 1C; Supplementary Table1). Recently, the MSL binding pattern to 
polytene chromosomes was suggested to reflect the distribution of active genes (Sass 
et al. 2003). Although the vast majority of genes bound by MSL1 are indeed active, a 
number of active genes on the X chromosome escape MSL1 binding (Alekseyenko et 
al. 2006; Gilfillan et al. 2006; Legube et al. 2006). Therefore, in order to address 
directly whether or not transcription is a prerequisite for targeting we analyzed 
targeting of the MSL complex to the m o f  gene in the absence of the endogenous 
promoter sequences (m o f24A prom). Clearly targeting to these lines was lost, as we 
did not observe MSL1 binding on the transgene in any of the lines studied (Figure 
1D; Supplementary Table1).
Although the results above suggest that the absence of transcription leads to 
the loss of MSL1 binding, it is possible that targeting sequences are present in the 
promoters of the respective genes as it was originally suggested for a number of genes 
(Baker et al. 1994). In order to address if the promoter requirement is due to a 
targeting signal embedded in the promoter sequence or solely due to transcriptional 
activation, m of was fused downstream of the tubulin promoter. The tubulin gene is 
located on chromosome 3 and therefore its promoter should not contain any X 
chromosome specific sequences. Interestingly, a tubulin  promoter driven m o f  
transgene (tub-mof) also showed ectopic recruitment of MSL1 (Figure 2A), as well as 
MSL3, MLE and MOF (Supplementary Figure 1). In contrast, tubulin driven 
expression of the p h o  gene (Klymenko et al. 2006), encoded on the fourth 
chromosome, did not show any MSL1 recruitment, further confirming the specificity 
of MSL1 binding to the m of gene (Supplementary Figure 2A; Supplementary Table1).
In order to study transcription dependent targeting at the same genomic 
position and thereby addressing any possible position effect variegation (PEV) related 
effects, we also created a transcription on/off assay by using a previously developed 
system that makes use of FRT-flip recombinase mediated excision of a yellow  gene 
inserted between the tubulin promoter and the gene of interest, in our case the m o f 
gene (Struhl and Basler 1993). When present, the yellow  gene blocks transcription
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from the tubulin promoter. This assay can therefore be used to study recruitment of 
MSL complex to the same location in the inactive and active state. Using this assay, 
we observed that m of was only recognized as a MSL1 target when transcription was 
allowed by excision of the yellow  gene (Figure 2 compare B and C; Supplementary 
Table1). We confirmed activation of transcription after excision of the yellow gene by 
rescuing the male specific lethality caused by the absence of MOF (data not shown). 
Since m o f driven by a tandem repeat of five GAL4 binding sites (UAS-mof) also 
showed targeting of MSL1 (Supplementary Figure 2B; Supplementary Table1), we 
conclude that targeting solely requires transcriptional activity irrespective of the 
promoter used. The determinant of targeting therefore, most likely is to be found in 
the gene region and not in the promoter sequence. Furthermore, the observation that 
UAS driven expression of m o f  without GAL4 activation also displayed MSL1 
recruitment suggest that transcription is required but the levels of transcription are not 
important.
A limited number of sites on the X chromosome are defined as high affinity 
sites because they have the ability to recruit partial complexes of MSL1 and MSL2 in 
the absence of the other MSLs (Kelley et al. 1999). Since m o f  is located in a 
cytological location of the previously mapped high affinity site at position 5c (Lyman 
et al. 1997; Demakova et al. 2003), we tested by DNA-FISH if this site coincides 
with the location of mof. Since homozygous msl-3083 male third instar larvae are rarely 
recovered, we used female flies expressing MSL2 in a msl-3083 mutant background. 
These flies assemble partial complexes on the X chromosome and are routinely used 
to study high affinity sites (Kelley et al. 1999; Kageyama et al. 2001; Dahlsveen et al. 
2006). As shown in figure 2D the m o f  endogenous gene is found in very close 
proximity to the high affinity site, but upon close examination appears to be not the 
site itself but just beside it (Figure 2D, see asterisks). We verified this result by 
crossing the genomic construct containing the m of locus (m o f 5) in an m sl-3 083 
background, which also showed no targeting (data not shown). Surprisingly however, 
when the tubulin driven m o f  transgene was crossed in an msl-3083 background we 
created what appeared to be a high affinity site, as we could observe recruitment of 
MSL1 in the absence of MSL3 (Figure 2D, arrow). We obtained similar results with 
this line in an mle1 mutant background albeit with a substantially weaker MSL1 
recruitment (data not shown).
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Taken together, the results above show that MSL complex is recruited to the 
m of gene in a transcription dependent manner. Our results suggest that also on other 
regions of the X chromosomes, otherwise known as lower affinity sites, partial MSL 
complexes are able to recognize their targets autonomously without MSL3 or MLE. 
We therefore propose that low affinity sites may override the requirement for MSL3 
or MLE if their expression is driven from a strong promoter such as tubulin. This is 
presumably due to combinatorial effect of chromatin modifications associated with 
high levels of transcription that may cooperate to expose certain DNA target 
sequences to MSL1 and MSL2, which may not be exposed otherwise.
mof
P{w+tub-mof}
(MSL3 mutant)
Figure 2. m o f trangene driven by a tubulin promoter is a target for 
MSL1 and overcomes the requirement for MSL3.
(A) Tubulin driven m of gene (B and C) Tubulin driven m o f  gene 
(tub>y+>mof) containing a yellow gene cassette between the promoter and the 
gene such that mof expression becomes inducible upon excision of the yellow 
gene cassette by expression of flippase. Recruitment of MSL1 before (B) and 
after (C) excision is shown. (D) Same as in A, however in this case the 
transgenic line carrying tub-mof was crossed into the msl-3083 mutant 
background by using females mutant for msl-3083 expressing low levels of 
MSL2 from an Hsp83 promoter. Recruitment of MSL1 to the tub-mof
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transgene is indicated by an arrow. Position of the endogenous mof gene is 
shown by an asterisk. Red cross (X) represents no transcription. DNA was 
stained with Hoechst 322 (blue).
MSL complex targeting is compromised in a-amanitin treated cells
Knowing that transcription is a prerequisite for binding of the MSL complex 
(Figure 2 B and C), we wished to test for the plasticity of the bound state. Somewhat 
conflicting hypotheses on the subject of timing and maintenance of targeting the MSL 
complex have been put forward recently. On one hand, the MSL complex is thought 
to be targeted in early development presumably following the present transcriptional 
pattern and maintained in the course of development irrespective of transcriptional 
changes (Alekseyenko et al. 2006; Legube et al. 2006). On the other hand subtle 
developmental changes in the binding pattern of the MSL complex on polytene 
chromosomes and the presence of genes in early development (6hr embryos) that are 
bound by MSLs but do not correlate with transcriptional status, as judged by RNA 
Pol II chromatin binding profiles (Gilfillan et al. 2006), suggest that differential 
binding takes place.
Since many MSL target genes are housekeeping genes that are continuously 
transcribed (Gilfillan et al. 2006; Legube et al. 2006), stable binding throughout 
development could be the rule with some differentially transcribed genes being the 
exception. In order to test this hypothesis, we blocked transcription by means of a -  
amanitin treatment in Schneider (SL-2) cells. We argued that if binding is maintained 
irrespective of transcriptional changes, genes should preserve their normal MSL 
binding pattern when transcription is blocked. As expected, after a 20hr a-amanitin 
(Pol II inhibitor) treatment transcript levels of most genes tested were significantly 
reduced compared to untreated control levels (Figure 3A). Visually the cells showed 
normal morphology (data not shown) and the protein levels of MSL1 and MOF were 
comparable to the control situation (Figure 3B). Furthermore, roX2 RNA levels in 
treated cells were mildly affected in comparison to the control situation, very likely 
reflecting a higher stability of this RNA (Figure 3A). In addition to the m of gene we 
tested four additional X chromosomal genes (UCP4A, SOCS16D, CG4061 and 
CG3016) by ChIP. Interestingly, all the tested genes show a dramatic reduction of 
MSL binding following a-amanitin treatment (Figure 3C). Intriguingly, MSL binding 
to the high affinity sites such as roX2 and 18D was significantly less susceptible to a-
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amanitin treatment, presumably reflecting their ability to recruit the complex 
ectopically independently of transcription (Kelley et al. 1999; Kageyama 2001; Oh et 
al. 2003; Oh et al. 2004). Consistent with these observations, we also found severely 
reduced staining of MSL1 on the X chromosomal territory in a-amanitin treated SL-2 
cells in comparison to the control cells (Figure 3D). These results suggest that MSL 
binding is reversible and depends directly on the transcriptional state of the targets. 
The rigid binding of MSLs therefore is not an embryonic irreversible pre-set 
condition but most probably reflects the continuous transcriptional activity of its 
targets.
Genic sequences contribute to MSL complex recruitment on the mof gene.
Although it is conceivable that targeting requires the transcription machinery 
to pass through the gene for a certain targeting signal to become exposed, it remains 
plausible that MSL binding is achieved by the recruitment of transcriptional activators 
to the promoter, e.g. in the scenario where the MSL complex slides along the DNA 
pushed forward by transcribing polymerase (Gilfillan et al. 2006). For this purpose we 
created a m o f  construct that has the m o f  endogenous promoter but in a reverse 
orientation (m of 3.5prom AS), such that transcription does not pass through the m o f 
gene. As is shown in Figure 4A this transgene is unable to recruit MSL1. Thus, 
transcription activation is not sufficient for targeting MSL1 to mof, instead 
transcription needs to run through the gene to reveal m of as an MSL target.
To date it remains unknown what the targeting signal embodies. A number of 
groups over the past years have attempted to identify a universal targeting sequence 
but despite these attempts, besides a number of short degenerative sequences with 
lim ited predictive power, no general binding sequence has been identified 
(Alekseyenko et al. 2006; Dahlsveen et al. 2006; Gilfillan et al. 2006; Legube et al. 
2006). It is possible that the predictive power of these sequences is limited because 
they need to be exposed in order to be recognized. It is conceivable therefore that for 
a target to be exposed, transcription needs to run through the gene whereby, if the 
signal involves degenerative DNA sequences, the orientation of transcription should 
not make a difference. Therefore, in order to test this hypothesis we placed a tubulin 
promoter at the 3 ’ end of the m o f  gene such that it would make a m o f  antisense 
transcript (tub-m of 4AS). If targeting involves a DNA element only to be recognized
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when the chromatin is in an open conformation, this transgene should retain its 
binding capacities for MSL1. This construct is indeed able to recruit MSL1 (Figure 
4B, top panel; Supplementary Table1). Interestingly, occasional spreading was 
observed on one of the lines (less than 5% of the nuclei, Figure 4B, bottom panel). 
This is possibly caused by the presence of targeting cues towards the 3 ’ end, that are 
now more exposed due to the close proximity of the tubulin promoter. In order to test 
if the 3 ’ end of m of is essential for targeting we created a m of construct similar to m of 
35 but now lacking 600bp of the 3 ’ end of the m of gene (m o f 9A 3prime). This 
construct, despite being transcriptionally active (Supplementary Figure 3), failed to 
recruit MSL1 in all lines observed (Figure 4C, Supplementary Table 1) which is in 
agreement with the overall binding preference of MSLs to the 3’ end of genes (Smith 
2001; Alekseyenko et al. 2006; Gilfillan et al. 2006). We next tested whether the 3’ 
end of the m o f  gene alone is sufficient to recruit MSL1 in the absence of the 
surrounding sequences. However, we were unable to observe recruitment of MSL1 on 
this fragment (Figure 4D).
Our data suggests that it is most likely that the targeting signal for the MSL 
complex is a DNA sequence embedded in the coding region of mof, only to be 
exposed when the gene is transcribed and that the sequences towards the 3 ’ end of 
m of are necessary but not sufficient for MSL1 recruitment as a small DNA element, 
out of context of the entire gene.
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Figure 3. Recruitment of MSL1 and MOF on X chromosomal genes is 
severely affected upon blocking transcription by a-amanitin. (A) Q-RT- 
PCR analysis of expression levels normalized to mock (100%) after a 20hr a- 
amanitin treatment. (B) Western blot analysis from whole cells extracts 
prepared from mock or a-amanitin treated cells. Western blots were probed 
with MSL1, MOF and Tubulin antibodies as indicated. (C) ChIP in SL-2
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cells with antibodies directed against MSL1, and MOF after 20hr mock or a- 
amanitin treatment. Levels of enrichment are determined by Q-PCR and 
depicted as the percentage recovery of input DNA. Enrichment on each gene 
was systematically tested using primer pairs located at the beginning, middle 
and end of genes. Position of the PCR probes with respect to the transcription 
start site (+1) is indicated on the X axis, for example for UCP4A 1st primer 
pair is located 367bp upstream of the transcription start site, and 2nd and 3rd 
primer pairs 612bp and 2860bp downstream, respectively. (D) 
Immunofluorescence with MSL1 (red) and Lamin (green) in Schneider (SL- 
2) cells of mock or a-amanitin treated cells. DNA was stained with Hoechst 
322 (blue).
Ectopic recruitment of MSL1 to CG3016 also involves transcriptional activity 
and sequences towards the 3 ’ end of the gene.
In order to test whether transcription dependent recruitment of the MSL 
complex was not unique for the m of gene but represented a more general feature of 
other X chromosomal genes, we next generated independent transgenes carrying 
CG3016 with or without its endogenous promoter sequences (CG30163, CG3016 25A 
prom, Supplementary Table 1). Similar to the m o f gene, we also observed ectopic 
recruitment of MSL1 to CG3016 in the presence of its promoter but not in its absence 
(Figure 5A and B). We were next interested in studying the contribution of the 
sequences towards the 3’end of the CG3016 gene in MSL1 targeting. For this purpose 
we mapped a 339bp region near the 3’ end of CG3016 which shows maximal MSL 
enrichment by ChIP and sequence similarity to the previously characterized 
conserved consensus sequence present on both roX1/2 high affinity sites 
(Supplementary Figure 4, (Park et al. 2003). We therefore created transgenes 
containing 339bp of this sequence as a monomer (P{w+ CG3016(1581-1920)}). 
Interestingly, we observed that similar to the m of 3’ end, this sequence alone was 
unable to recruit MSL1 ectopically. Intriguingly however, m ultim erisation 
(containing 5 tandem repeats, P{w+ CG3016(1581-1920) 5mer}) of this sequence 
restored binding of MSL1, indicating that different from the high affinity sites that 
recruit MSLs as a ~300bp monomer (Kageyama 2001; Park et al. 2003; Oh et al. 
2004) but similar to the m of situation, the affinity of MSL1 for the CG3016 sequences
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is too low to be recognized when placed out of context of the gene itself, but can be 
revealed upon multimerisation (Figure 5D).
The three previously mapped high affinity sites (roX1, roX2 and 18D) have 
been shown to maintain their ability to recruit MSL1 in a msl-3083 mutant background 
as a small ~300bp monomer for roX1/2 and as a multimer in the case of the 18D high 
affinity site (Kageyama 2001; Park et al. 2003; Oh et al. 2004). Although CG3016 is 
not a high affinity site we were interested to test if multimerisation of a low affinity 
site could overcome the requirement for MSL3. Therefore to address this issue (as 
described above in Figure 2D), we crossed the transgenic flies carrying the CG3016 
multimer with flies expressing MSL2 in a msl-3083 mutant background and analyzed 
MSL1 binding to female polytene chromosomes. Interestingly, we observed that the 
CG3016 multimer failed to recruit MSL1 in msl-3083 mutant background (Figure 5E).
These results show that similar to the m of gene, MSL complex recruitment on 
CG3016 gene requires transcriptional activity and sequences embedded within the 
body of the gene. We also show that even though multimerisation of 3’ of CG3016 
restores the binding of MSL1 in the wild-type context, the affinity of MSL1 for this 
CG3016 sequence is too weak to be maintained in the absence of MSL3.
Discussion
In this study, we provide direct evidence for transcription dependent 
recruitment of the MSL complex to X-linked genes. We show that passage of the 
transcription machinery through the gene is important whereas the type of promoter 
and the direction of transcription is not. Our data demonstrates that the recruitment 
signal lies within the transcribed portion of the gene and that targeting occurs 
independently of neighboring nucleation sites as we can successfully assess 
recruitment of X linked genes on autosomal locations in a transcription dependent 
manner. Our data support a model for MSL complex targeting to transcriptionally 
active X linked genes, that encode a certain combination of small degenerative target 
sequences in their transcribed region.
It has been proposed previously that one can create MSL complex binding 
sites on X chromosomal regions, normally devoid of the MSL complex, by driving 
strong transcription via 14 tandem repeats of GAL4 binding sequences (Sass et al.
2003). However, because integration of the EP lines used was random and the sites of
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insertion were not characterized, the nature of the transcribed unit was unclear and 
therefore any assumptions made about the importance of certain sequences, direction 
or strength of transcription of the targeted unit remained speculative. Furthermore, 
since the autosomal EP lines failed to recruit MSL complex it remained unclear to 
what extent the X chromosomal context played a role in MSL recruitment on these 
insertion sites. It may therefore be important to study MSL targeting autonomously, 
out of the X chromosomal context, to avoid the complication that may be caused by 
high local concentration of MSLs on the X chromosome in combination with strong 
transcriptional activation as previously reported (Sass et al. 2003). Furthermore, in 
contrast to what has been proposed previously (Sass et al. 2003), our data suggests 
that transcription alone is unlikely to be the sole targeting signal. Firstly because 
many genes on the X chromosome are
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Figure 4. Targeting by MSL1 to the m of gene involves DNA sequences 
embedded in the coding region. MSL1 immnuostaining (green) in 
combination with DNA-FISH (red) for the location of the transgene for 
insertions containing mof with an antisense promoter (A), tubulin driven 
antisense mof gene (B), endogenous promoter driven mof derivative lacking
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670bp of the 3’prime end (C), or endogenous promoter driven 3’ end of mof 
(1863-2533bp) (D). Recruitment of MSL1 to the transgenes is indicated by 
an arrow. DNA was stained with Hoechst 322 (blue).
transcribed but not targeted by MSLs (Alekseyenko et al. 2006; Gilfillan et al. 2006; 
Legube et al. 2006). And secondly, as shown in this study, the m o f gene looses its 
targeting properties without sequences towards the 3 ’ end while still being transcribed 
(Figure 4 and Supplementary Figure 3).
Our data show that most likely the targeting signals for the MSL complex 
include DNA sequences embedded in the coding regions of m of and CG3016 only to 
be exposed when the gene is transcribed. These target sequences are found towards 
the 3 ’ end and are necessary but not sufficient for MSL1 recruitment, out of context 
of the entire gene. It remains possible however that additional elements also 
contribute to MSL1 target recognition. Such elements could either be DNA sequences 
or simply other chromatin-associated factors/modifications that facilitate MSL1 target 
recognition in a chromatin context. Alternatively a RNA secondary structure might be 
involved in MSL recruitment. Such a RNA structure would be a feature of the mRNA 
sequence. Since the secondary RNA structure formed is independent of the 
orientation of transcription, the situation created in the case where m of is transcribed 
in an antisense direction would be similar if not identical to the situation where m of is 
transcribed in sense orientation. It is unlikely however, that a natural antisense 
transcript is involved in MSL recruitment because a m of transgene without a promoter 
failed to recruit MSL1 where it would still have the potential to produced an antisense 
RNA molecule, if this was the case (Figure 1D).
We failed to find any predicted target sequences in the m of gene and although 
the CG 3016  gene shows some similarity to the roX1/2  high affinity consensus 
sequences, CG3016  does not behave as a high affinity site, as judged by MSL3 
dependent recruitment. This once again emphasizes the difficulty of predicting MSL 
target sequences. In agreement with previous studies, we conclude that most 
probably the nature of these sequences determines the affinity of MSLs for its targets 
and not the level of transcription as any type of promoter reveals m o f  as a target 
(Dahlsveen et al., 2006; Gilfillian et al., 2006).
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Figure 5. Transcription dependent targeting of MSL1 to CG3016 and 
the identification of a targeting sequence towards the 3’ prime end of the 
gene. MSL1 immnuostaining (green) in combination with DNA-FISH (red) 
on an autosomal P-element insertion carrying CG3016 with (A) or without 
(B) its endogenous promoter. A 339bp fragment (represented by a white box) 
corresponding to nucleotide positions 1581-1920bp from the transcription 
start site of CG3016 (C), multimerization of the 339bp sequence (5 tandem 
repeats) in a wild-type (D) and in an msl-3083 mutant background (E). 
Recruitment of MSL1 to the transgenes is indicated by an arrow. DNA was 
stained with Hoechst 322 (blue).
Our data may also explain in part the limited predictive power of MSL 
binding, since targeting only occurs when the gene is transcribed and thus the 
sequence is exposed. Therefore, MSL binding predictions should also take into 
account the transcription state of genes or possibly the chromatin state, for example 
by creating a genome wide DNaseI map (Sabo et al. 2004) of the X chromosome.
Unlike the full length m of or CG3016 genes, the affinity of MSL1 for the 3 ’ 
end sequences of the m o f and CG3016 genes is not sufficient for visualization on 
polytene chromosomes. Furthermore, even though multimerisation of sequences 
towards the 3 ’ of CG3016 restores the binding of MSL1 in the wild-type context, the
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affinity of MSL1 for this CG3016 sequence is too weak to be maintained in the 
absence of MSL3. These results show that on the one hand there are “high affinity 
sites” such as roX genes, that display transcriptional independent MSL targeting sites, 
that are able to recruit MSLs as relatively small DNA sequences (Kageyama et al. 
2001; Oh et al. 2004). And on the other hand the majority of sites present on the X 
chromosome are “low or moderate affinity sites” for MSL1 that require exposure of 
their target sequences presumably by transcriptional activity or artificially by 
multimerisation in order to be recognized as a MSL target sequence. We therefore 
propose a model of MSL recruitment to the majority of X-linked target genes based 
on a combination of active transcription and the presence of DNA target elements.
Future bioinformatics studies encompassing several MSL target genes should 
reveal whether the 3 ’ end of X linked genes harbors a particular consensus sequence, 
binding sites for other factors or even a particular secondary structure that together 
with transcriptional activity contributes to MSL target recognition of X-linked genes.
Materials and Methods 
Chromatin-Immunoprecipitation (ChIP)
All ChIP experiments were performed at least three times using independent 
chromatin preparations as described in (Orlando and Paro 1993). Briefly, SL-2 cells 
were grown in Schneider medium (Gibco) containing 10% FCS. 1 x 108 cells were 
cross-linked with formaldehyde for 8 min. Sonication was performed (26x 30 sec) at 
maximum power (Bioruptor,CosmoBio) in lysis buffer (50 mM HEPES/KOH at pH 
7.5, 500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% DOC, 0.1% SDS + 
Complete protease inhibitors (Roche)) . 100 ^g  chromatin and 3 ^ l of polyclonal 
antibody was used per IP (MSL1, MSL3 raised in rats and MOF raised in rabbit as 
described previously (Mendjan et al. 2006). Immunoprecipitated complexes were 
isolated by adding protein A/G-Sepharose (Roche) followed by four washing steps: 
2x lysis buffer, 1x DOC buffer (10 mM Tris pH 8, 0.25 M LiCl, 0.5% NP-40, 0.5% 
DOC, 1 mM EDTA), 1x TE pH 8. DNA was eluted in 1x elution buffer (1%SDS, 
0.1M NaHCO3) 20 min at room temperature followed by reversal of crosslinks at 
65°C overnight. DNA was purified by a 30min incubation 37°C RNaseA (0.2mg/ml), 
2hr Proteinase K (0.05mg/ml) followed by phenol/chlororform extraction and DNA
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precipitation. Each ChIP was resuspended in 100^l TE.
Quantitative PCR
For the spanning of the cytological location 5c5 primers were designed to space 
approximately every 500bp, which is the average size of the chromatin used in this 
study (primers available upon request). The roX2, runt and gapdh primer pairs are as 
described in (Legube et al. 2006). Q-PCR analysis of the ChIP was performed using 
the SYBR Green PCR master mix (Applied Biosystem), 100 ng of each primers, and 1 
^ L  of the immunoprecipitated DNA, in an ABI7500 Real-time PCR Instrument 
(Applied Biosystem). The formula [%ChIP/input] = [E(ainput-CtChIP) * 100%] (where E  
represents the primer efficiency) was used to calculate the percentage recovery after 
ChIP as compared to input. For the analysis of the RNA levels, RNA was first 
reverse-transcribed using the SuperScript RT (Invitrogen), and 500 ng of random 
hexamer. One microliter of the cDNA was then subjected to real-time PCR using the 
SYBR Green PCR master mix (Applied Biosystem) and 10pmol/^l of each primer. 
The primers designed in the middle of the genes in the ChIP experiment were used for 
the analysis of the transcript levels. For the a-amanitin ChIP experiment, primer pairs 
were designed to amplify 100-200bp fragments in the beginning, middle and end of 
genes. For the Q-RT-PCR analysis of the transcript levels the RT reaction was 
performed as described in the RT-PCR section below. RNA levels were normalized to 
mitochondrial RNA and depicted as percentage recovery of input DNA after a -  
amanitin treatment compared to mock treated cells.
RT-PCR
For RT-PCR in Supplementary Figure 3, third instar larvae were snap frozen in liquid 
nitrogen and crushed with a mortar and pestle. RNA was then collected following 
instructions from the Qiagen RNeasy kit. Reverse transcriptase (RT) reactions were 
performed with random hexamers using Invitrogen SupersciptII. RT reactions were 
loaded as a dilution series (1, 0.1, and 0.001 ^ l of RT mix). For RT-PCR on the 
transgenes a primer specific for the CaSpeR vector was used in combination with a 
m of specific primer. In contrast, for the expression of the endogenous m of gene both 
primers were encoded within the coding sequence of mof.
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a-am anitin treatment
SL-2 cells were grown to a density of approximately 4 x 106 and treated for 20hr with 
either a-amanitin (15 ^g/_l (Sigma)) or plain insect medium. 1 x 108 cells were used 
for ChIP, 1x106 cells were used to make a nuclear extract as described in (Akhtar et 
al. 2000) and 1 x 106 cells were used for RNA purification. The samples were 
analysed by SDS PAGE followed by Western blot analysis.
Immuno-FISH on polytene staining
Preparation of polytene chromosomes and immuno- FISH were performed as 
described
(http://www.igh.cnrs.fr/equip/cavalli/Lab%20Protocols/Immunostaining.pdf). The 
location of the target genes was detected with specific probes made against the mini­
white gene present in our transgenic cassettes. The probes for FISH were generated 
using random primed dioxygen-dUTP labeling (Roche) of the mini-white gene. 
MSL1, MSL3, MOF and MLE antibodies were used at 1:500 dilution (Mendjan et al. 
2006). Images were captured with an AxioCamHR CCD camera on a Zeiss 
Axiovert200M microscope using a 100x PlanApochomat NA 1.4 oil immersion 
objective.
Fly genetics
Flies were raised on standard cornmeal-agar-yeast medium at 18 °C or 25 °C. To 
generate transgenic flies carrying different insertions all fragments were cloned using 
PCR based strategy (primers available on request) into the p[PCaSpeR]4 (Pirrotta 
1988) vector, except for w-;P{w+ UAS-mof} and w-;P{w+ tub-mof} where the m o f 
cDNA was cloned downstream of multiple GAL4 binding sites pP[UAST] (Brand 
and Perrimon 1993) and downstream of a 2.4 kb tubulin  promoter sequence 
respectively. For the line y- w-;P{w+ tub<yellow+ >m of } the yellow cassette was 
subcloned from p[PJ35] (Struhl and Basler 1993) into the tub-mof vector. Transgenic 
flies were made by P-element-mediated transformation of the w1118 (also referred to as 
w-) recipient stock (Rubin and Spradling 1982). Lines were selected for second or 
third chromosome insertions. To generate msl-3083 mutant larvae that carry P{w+ tub- 
m o f } or P{ w+ cg3016 1581-1920 5mer}. y- w-; msl-3083 {hsp83-msl-2} females were 
crossed to w-; m sl-3 083 P{w+ tub-mof}/TM6C, Sb Tb or P{ w+ cg3016 1581-1920 
5mer}/TM6C, Sb Tb males. msl-3083 female larvae, w-; msl-3083 P{hsp83-msl-2}/msl-
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3083 P{w+ tub-mof} were distinguished by the absence of the Tb phenotype. To create 
y- w-; P {w+ tub-mof} from y- w-; P{ w+ tub <y+< m of }, male flies were crossed to 
female y w P{70FLP}3F and progeny was subjected to heat shock at various times 
during development. Since the stocks were mutant for the endogenous y gene progeny 
was selected for a loss of the y+ marker.
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Supplementary Figure legends
Supplementary Figure 1
Recruitment of MSL1, MSL3, MLE, and MOF on tubulin driven m of transgene 
(P{w+tub-mof}). Recruitment of MSL proteins to the transgene is indicated by an 
arrow. DNA was stained with Hoechst 322 (blue).
Supplementary Figure 2
(A) MSL1 is not recruited on transgene expressing autosomally encoded pho gene.
(B) MSL1 is recruited on transgene carrying GAL4UAS driven m o f  gene. 
Recruitment of MSL1 to the transgenes is indicated by an arrow. DNA was stained 
with Hoechst 322 (blue).
Supplementary Figure 3
Expression analysis by RT-PCR of the lines P{w+ m o f '9A 3prime}(lanes 7-9) and P{ 
w+ m of 3prime} (4-6) as compared to endogenous m of expression (WT, lanes 1-3) to 
detect levels of m of RNA (top panel). As a loading control mitochondrial ribosomal 
(mt:lr) RNA was used (bottom panel). M represents DNA ladder. RT reactions were 
loaded as dilution series as shown.
Co-transcriptional recruitment of the dosage compensation complex 67
Supplementary Figure 4
Sequence alignment using ClustalW (http://www.ebi.ac.uk/clustalw/) of the roX2 
high affinity site with the 339bp CG3016 sequence. In red are conserved sequences 
between roX1/roX2 (Park et al. 2003). In blue are sequence motifs involved in MSL 
complex binding (Dahlsveen et al. 2006).
Supplementary Table 1
Number of independent fly lines tested for each transgene used in this study. 
Recruitment of MSL1 on each line was scored and the lines showing MSL1 
recruitment are indicated.
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Abstract
Dosage compensation, m ediated by the MSL complex, regulates X 
chromosomal gene expression in Drosophila. High-resolution, genome-wide analysis 
revealed differential binding behavior of histone H4 lysine 16 (H4K16) specific 
histone acetyltransferase MOF whether the target gene is located on the X 
chromosome versus on autosomes. More specifically, on the male X chromosome, 
where MSL1 and MSL3 are preferentially associated with the 3 ’end of dosage 
compensated genes, MOF displays bimodal distribution binding primarily to 
promoters as well as the 3 ’ ends of genes. While on MSL1/MSL3 independent X- 
linked genes and autosomal genes in males and females, MOF binds primarily to 
promoters. Binding of MOF to autosomes is functional, as H4K16 acetylation and the 
transcription levels of a number of genes are affected in MOF-depleted cells. MOF is 
therefore involved not only in the onset of dosage compensation, but also acts as a 
regulator of gene expression in the Drosophila genome.
Introduction
Genetic material does not exist freely in the cell but is in complex with histone 
proteins to form chromatin. Histones are subject to a wide variety of post-translational 
modifications that impose changes on chromatin structure. Among the various histone 
modifications, acetylation is one of the best studied (for reviews see (Kurdistani and 
Grunstein, 2003; Lee and Workman, 2007; Yang and Seto, 2007)). X-chromosomal 
dosage compensation in Drosophila melanogaster is a model system that is used to 
gain better understanding of broad chromosome-wide transcriptional regulation by 
hyper-acetylation (for review see (Lucchesi et al., 2005; Mendjan and Akhtar, 2006; 
Straub and Becker, 2007)).
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Dosage compensation is a process that balances the expression of sex-linked 
genes in species that have evolved unequal numbers of sex chromosomes. In 
D rosophila  this involves hyper-activation of the single male X chromosome to 
equalize for the combined transcriptional activity of both female X chromosomes. 
This process is regulated by the MSL complex, which consists of at least five male- 
specific lethal proteins (MSL1, MSL2, MSL3, maleless (MLE) and males-absent-on- 
the-first (MOF)) and two non-coding RNAs (roX1 and roX2) (for review see (Straub 
and Becker, 2007)).
Although the individual components of the MSL complex have been studied 
extensively, the m olecular mechanisms underlying the process of dosage 
compensation remain poorly characterized. MSLs are thought to function, in part, in 
the recruitment and activation of MOF at the X chromosome. MOF is a histone acetyl 
transferase (HAT) which specifically acetylates lysine 16 of Histone H4 (H4K16Ac), 
a modification found highly enriched on the male X chromosome (Akhtar and 
Becker, 2000; Bone et al., 1994; Hilfiker et al., 1997; Smith et al., 2000).
The role of H4K16Ac in transcriptional regulation is not completely 
understood. Drosophila  MOF protein targeted to a heterologous promoter by the 
GAL4 DNA binding domain releases chromatin-mediated transcriptional repression 
by H4K16Ac in yeast (Akhtar and Becker, 2000) and causes chrom atin 
decondensation on the male X chromosome in Drosophila  (Corona et al., 2002). 
Although, H4K16Ac does not correlate with active genes in yeast (Kurdistani et al.,
2004), it is specifically associated with the activity of a subset of genes, whereas all 
other acetylation marks on histone H4 exhibit an additive effect (Dion et al., 2005). 
H4K16Ac modifications pose a structural constraint on higher-order chromatin 
formation; it is therefore possible that maintenance of transcriptional potential could 
be one of its functions. In this role, H4K16Ac would serve to limit the association of 
repressive protein complexes and, in tandem, relax the chromatin fiber to permit 
accessibility of the transcriptional machinery (Shogren-Knaak et al., 2006). At 
present, the distribution of H4K16Ac across the length of gene loci, together with its 
presumed role in chromatin de-condensation, has given rise to the hypothesis that the 
MSL complex is involved in transcriptional elongation (Smith, 2001).
Although MSLs are mainly studied in Drosophila, all MSL proteins have 
conserved orthologs in mammals (Marin, 2003). This implies functional conservation
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in species with radically different dosage compensation mechanisms. Not only do the 
human MSLs (hMSL) form a complex like in Drosophila, most of their interaction 
partners are also conserved (Mendjan et al., 2006; Smith et al., 2005; Taipale et al.,
2005). Furthermore, MOF in D rosophila  is the only MSL protein to bind all 
chromosomes independently of the MSL complex in both males and females (Bhadra 
et al., 1999). These properties, together with evidence of evolutionary conservation, 
suggest a role for both MOF and H4K16Ac in transcriptional regulation beyond the 
process of dosage compensation.
To gain insight into the role of MOF in the regulation of gene expression, we 
performed a comprehensive genome-wide analysis of MOF/MSL bound DNA by a 
series of chromatin immunoprecipitations directed against specific MSL proteins, 
followed by hybridization to high-resolution tiling arrays (the ChIP-chip method; see 
(Horak and Snyder, 2002)). This strategy allowed us to generate binding profiles for 
MSL1, MSL3 and MOF, along with H4K16 acetylation, in “male” Schneider (SL-2) 
cells as well as MOF and H4K16Ac in “female” Kc cells (see below). These analyses 
were complemented with microarray-based gene expression profiles of SL-2 cells 
depleted of MSL1, MSL3 and MOF, and of MOF-depleted Kc cells.
Our data reveal MOF as a transcriptional regulator, not only on the X 
chromosome but also on autosomes. Intriguingly, MOF on the X chromosome 
associates with promoters and the 3’ end of genes whereas on autosomes and the 
female genome MOF associates prim arily with promoters. Furthermore, an 
accumulation of H4K16Ac marks is observed over entire gene loci on the X 
chromosome, whereby this pattern is a direct reflection of MOFs activity, while on 
autosomes, acetylation was found to peak towards the 5’end of target genes. 
Interestingly, we found that binding to 3' ends of genes by MSL1, MSL3 and MOF is 
interdependent on the X chromosome; however MOF association to promoter­
proximal regions was found to be independent of MSL1, similar to the binding site 
distribution across the autosomes. It therefore appears that the role of the MSL 
complex members is to recruit MOF towards the gene interior, allowing more 
extended acetylation toward the 3’ end. These results provide interestinginsights into 
the mechanism of MSL complex recruitment on dosage-compensated genes and 
reveal an unprecedented role of MOF on autosomes independent of the MSL 
complex.
MOF as a regulator of dosage compensation and gene expression 73
Results
Correlated MSL binding and H4K16 acetylation on the male X chromosome
We created high-resolution (35bp) genome-wide DNA-binding profiles of 
MSL1 and MSL3, MOF and H4K16Ac in Drosophila Schneider SL-2 cells, using the 
ChIP-chip method to hybridize chromatin-immonuprecipitated DNA to Affymetrix 
tiling arrays. To equalize for the level of histones, control ChIP samples were isolated 
using a Histone H4 specific antibody. ChIP DNA samples were produced and 
hybridized as three independent biological replicates, which showed highly 
reproducible binding profiles (Supplementary Figures 1 and 2). To facilitate unbiased 
comparisons across different ChIP-chip experiments, we considered the topmost one 
percent of enriched binding-site loci scored for each condition (see Experimental 
Procedures).
The use of genome-wide tiling arrays makes it possible to study the 
localization of MSL1, MSL3, MOF and H4K16Ac sites systematically, on all 
chromosomes and at high resolution. To elucidate the properties of DNA association 
independently of dosage compensation, we analyzed binding site occupancy of each 
protein over the X chromosome and the autosomes in parallel. Chromatin profiling of 
MSL1, MSL3, MOF as well as H4K16 acetylation exhibited a high degree of 
coincidence across the X chromosome (Figure 1A). As expected, we observed a clear 
preference for MSL1, MSL3, MOF to bind the X chromosome rather than autosomes 
(Supplementary Figure 3). Further analysis revealed that 534 X-chromosomal genes 
were bound by the three MSL proteins (Figure 1B).
To further assess the accuracy of our approach, we examined a large (~150kb) 
region of the X chromosome for binding of MSL1 and MOF with three independent 
chromatin samples followed by quantitative real-time PCR (qRT-PCR). In addition, 
primers were designed to amplify the roX2 and runt genes; these serve as positive and 
negative controls, respectively, and have been used routinely for this purpose in other 
studies of the MSL complex (Kind and Akhtar, 2007; Legube et al., 2006; Smith,
2001). These qRT-PCR results correlate well with the profiles generated by global 
ChIP-chip analyses (Supplementary Figure 4).
MSL1 and MSL3 are bound to few autosomal genes whereas MOF displayed 
extensive binding to autosomes (Figure 1B and 1C and Supplementary Figure 5).
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Consistent with these observations, MOF was also found to associate globally to 
autosomes on polytene chromosomes, albeit with a clearly lower incidence of binding 
than on the X chromosome (Figure 1D). In contrast to MOF, only a small number of 
sites could be observed for MSL3 on autosomes (Figure 1D). We therefore conclude 
that in contrast to MSL1 and MSL3, which preferentially bind to the X chromosome, 
MOF also binds extensively to autosomes.
MOF displays a bimodal binding pattern on X-chromosomal genes
As demonstrated here, MSL1, MSL3, and MOF display a clear preference for 
binding to loci across the X chromosome. Given these results, we then examined 
individual gene components to elucidate patterns of binding to coding sequences, 
introns and untranslated regions. Consistent with previous observations (Alekseyenko 
et al., 2006; Gilfillan et al., 2006; Legube et al., 2006), MSL1, MSL3, and MOF bind 
preferentially to gene loci over both intergenic regions and UTRs on the X 
chromosome (Supplementary Figure 6A-C). In striking contrast, however, a 
significant enrichment of MOF binding sites to autosomal intergenic regions and 5' 
UTRs was observed, whereas binding to 3' UTRs is nearly absent. (Supplementary 
Figure 6C, E). This marked shift in binding preference suggests diversified functional 
association of MOF to intragenic regions between the X chromosome and autosomes.
To establish an average binding profile across regulated gene loci, 
oligonucleotide probesets corresponding to bound genes (on X chromosomes and 
autosomes) were analyzed for relative binding frequency along the scaled lengths of 
gene loci (Figure 2A-D, Supplementary Figure 7). In this manner, it can be seen that 
H4K16 acetylation gradually increases towards the 3 ’ ends of genes, similar to the 
pattern displayed by MSL1 and MSL3. Surprisingly however, MOF displays a 
bimodal pattern of binding towards the beginning and the 3 ’end of genes (compare 
Figure 2C to A, B and D). Similar results were obtained by performing the analyses 
reporting only one significant bound probe per gene per standardized region to 
account for gene length effects (data not shown). Distribution of individual probe 
intensities across individual genes further
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Figure 1. High resolution map of MSL1, MSL3, MOF and H4K16Ac 
chromatin profiling in D rosophila  SL-2 cells. MOF binds the X 
chromosome in association with the MSL complex, but binds independently
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to autosomes. (A) Topmost 1% ranked binding loci of MSL1, MSL3, MOF 
and H4K16Ac on a section of the X chromosome representing 1.5 Mb.
Flybase (+) and (-) represents the location of genes on the forward and 
reverse DNA strands respectively. Coordinates represent the position on the 
corresponding chromosome (B) Overlap of MSL1, MSL3 and MOF target 
genes on the X chromosome and autosomes. (C) Comparison of the 
distribution of MSL1, MSL3 and MOF binding on the chromosome arm 2L.
(D) Immunostaining of polytene chromosomes from male third instar larvae 
using antibodies against MOF (red) and MSL3 (green). DNA staining is 
shown in blue (Hoechst 322).
MOF displays a bimodal binding pattern on X-chromosomal genes
As demonstrated here, MSL1, MSL3, and MOF display a clear preference for 
binding to loci across the X chromosome. Given these results, we examined 
individual gene components to elucidate patterns of binding to coding sequences, 
introns and untranslated regions. Consistent with previous observations (Alekseyenko 
et al., 2006; Gilfillan et al., 2006; Legube et al., 2006), MSL1, MSL3, and MOF bind 
preferentially to gene loci over both intergenic regions and UTRs on the X 
chromosome (Supplementary Figure 6A-C). In striking contrast, however, a 
significant enrichment of MOF binding sites to autosomal intergenic regions and 5' 
UTRs was observed, whereas binding to 3' UTRs is nearly absent. (Supplementary 
Figure 6C, E). This marked shift in binding preference suggests diversified functional 
association of MOF to intragenic regions between the X chromosome and autosomes.
To establish an average binding profile across regulated gene loci, 
oligonucleotide probesets corresponding to bound genes (on X chromosomes and 
autosomes) were analyzed for relative binding frequency along the scaled lengths of 
gene loci (Figure 2A-D, Supplementary Figure 7). In this manner, it can be seen that 
H4K16 acetylation gradually increases towards the 3 ’ ends of genes, similar to the 
pattern displayed by MSL1 and MSL3. Surprisingly however, MOF displays a 
bimodal pattern of binding towards the beginning and the 3 ’end of genes (compare 
Figure 2C to A, B and D). Similar results were obtained by performing the analyses 
reporting only one significant bound probe per gene per standardized region to 
account for gene length effects (data not shown). Distribution of individual probe 
intensities across individual genes further confirmed that this bimodal binding of
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MOF represent the bonafide behavior of MOF on individual genes rather then a 
simple superimposition of two distinct classes of sites on the X chromosome (Figure 
2E and Supplementary Figure 8).
Complementary analyses of MOF binding at transcription start and stop sites 
revealed that MOF binding peaks at promoter regions, on autosomal and X 
chromosomal target genes. In addition, MOF binds along the body and 3’ end of 
genes located on the X chromosome (Supplementary Figures 9, 10). MOF is enriched 
approximately 0-500bp upstream of the transcription start site, which we refer to 
hereafter as MOF promoter binding (Supplementary Figure 9). Intriguingly, the 
H4K16Ac profile across the X chromosome is enriched towards the 3’ ends of genes 
in a pattern very similar to the MSL3 profile (compare Figure 2B with 2D). The 
intensity of MOF binding at 3 ’ end of X-linked genes was significantly higher 
compared to the 5’ends (p < 4e_08) (Supplementary Figure 11A). In contrast, MOF 
binding on autosomes was significantly higher at 5’ends of autosomal genes (p 0.014) 
(Supplementary Figure 11B).
It therefore appears evident that in SL-2 cells MOF binds to promoters as well 
as throughout the body of X-chromosomal genes, with a binding-peak at 3 ’ends. This 
in contrast to the activity observed on autosomes, where MOF binding peaks at 
promoters.
MOF binds promoters in Kc cells
Differential binding of MOF to X chromosomal genes and autosomes with 
respect to MSL1 and MSL3 in SL-2 cells (Figure 2C, Supplementary Figure 7C) 
prompted us to perform genome-wide analysis of MOF binding and H4K16Ac in Kc 
cells. In Kc cells, MSL2 is translationally repressed by SXL as part of the sex 
determination pathway (Bashaw and Baker, 1995; Zhou et al., 1995). Consequently, 
the MSL complex cannot assemble, and its members are unstable (Kelley et al., 
1995). Kc cells may therefore be regarded as "female” cells as opposed to “male” SL- 
2 cells where MSL complex members are expressed and exhibit the classical staining 
pattern of the male X chromosome (Duncan et al., 2006; Mendjan et al., 2006).
In contrast to the pattern of activity observed in SL-2 cells, MOF binding sites 
and H4K16Ac marks are not restricted to the X chromosome but rather are distributed
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lengths and the relative position of significant probes was computed. Bars
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represent the number of significant probes in a given region. A continuous fit 
of the distribution is depicted in red. MOF binds to promoters (5’ ends) and 
towards the 3' ends of X-chromosomal gene loci. This bimodal binding 
pattern is different from the primarily 3’ enrichment of MSL1, MSL3 and 
H4K16Ac (A-D). TSS represents (transcription start site) and END 
represents (transcription stop site). (E) MSL1, MSL3 and MOF binding 
intensity on a single X chromosomal target gene (PH1). Flybase (+) and (-) 
represents the location of genes on the forward and reverse DNA strands 
respectively. Coordinates represent the position on the corresponding 
chromosome.
evenly across the genome in Kc cells (Supplementary Figure 3; Supplementary Figure 
6E, F; Figure 3A). In addition, MOF does not display a bimodal distribution across 
gene loci in Kc cells, but instead is mainly restricted to promoters with a concurrent 
shift in the H4K16Ac profile from 3 ’ to 5 ’ enrichment (Supplementary Figure 9). 
Notably, when in SL-2 cells the topmost-ranked 1% significant autosomal gene 
targets were analysed independently of the X chromosome, the MOF and H4K16Ac 
profiles appear nearly identical to those obtained from Kc cells (Figure 3B).
Furthermore, a significant number of genes are similarly bound by MOF on 
autosomes in SL-2 and Kc cells (Figure 3C). In keeping with these results, the 
binding-site occupancy is nearly identical between both cell types (Supplementary 
Figure 12). Interestingly, we found that the intensity of 5 ’ MOF binding was 
significantly higher on the X chromosome versus autosomes in both SL-2 cells (p < 
2e_18) and Kc cells (p < 3e_08) (Supplementary Figure 13). Furthermore, MOF 
binding correlated highly significantly with H4K16Ac occupancy in both SL-2 (p < 
2.2e-16) and Kc cells (p < 2.2e-16) (Figure 3D). We also found that approximately 
80% of all MOF bound targets (autosomes and X chromosomes) are active genes in 
both SL-2 and Kc cells (Supplementary Figure 14; see Supplementary Experimental 
Procedures). Among the 1980 genes bound by MOF in the two cell lines, Gene 
Ontology (GO) analysis revealed a number of statistically over-represented biological 
processes related to the cell cycle (Supplementary Figure 14C, Supplementary Table 
1). Similarly, a variety of other biological processes were found to be significant 
among genes bound independently in either SL-2 (971 genes) or Kc cells (943 genes). 
These results are summarized in Supplementary Tables 2 and 3.
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Taken together these results demonstrate that MOF, in addition to binding 
across the body of genes on the male X chromosome, binds promoters of 
transcriptionally active genes in both SL-2 and Kc cells on all chromosomes.
MOF binding to promoters is independent of MSL1
Global analyses in both cell types revealed that MOF resides on promoters on 
all chromosomes (Figure 2 and Figure 3). Invariant binding of MOF to promoters of 
X-linked genes between SL-2 and Kc cells (Figure 3B) argues for MSL-independent 
targeting of MOF to promoters on the X chromosome. To test this hypothesis, we 
performed RNAi-mediated depletion of MSL1 followed by ChIP-qRT-PCR analysis 
to study MOF recruitment. We analyzed the four X-linked genes CG8173, par-6, 
ucp4a  and the previously identified “high-affinity site” roX2, where MSL1 
recruitment has been shown to be MOF independent (Kelley et al., 1999; Park et al.,
2002). PCR primers were designed to span the promoter (P1), middle (P2) and end 
(P3) of each gene (See Experimental Procedures). In MSL1 depleted cells, binding of 
MOF is severely compromised across the lengths of all four genes tested as compared 
to the control EGFP RNAi-treated cells, whereas MOF binding to promoter-proximal 
regions remained unaffected (Figure 4A-D).
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Figure 3. MOF is bound to promoter-proximal regions on autosomes in 
SL-2 and Kc cells. (A) Binding profile of MOF and H4K16Ac in SL-2 and 
Kc cells on about 1 Megabase (MB) region of chromosome 2L. Flybase (+) 
and (-) represents the location of genes on the forward and reverse DNA
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strands respectively. Coordinates represent the position on the corresponding 
chromosome. (B) Probe frequency and density measurements of MOF 
binding and H4K16Ac to gene loci on the autosomes in SL-2 and Kc cells.
Default binding of MOF to promoters in SL-2 and Kc cells results in a shift 
in the H4K16Ac pattern towards the 5' end across gene loci. (C) Overlap in 
MOF target genes between SL-2 and Kc cells on autosomes. (D) MOF 
binding significantly correlates with H4K16Ac in both SL-2 (p < 2e-16) and 
Kc cells (p < 2e-16).
Consistent with the ChIP-chip analysis, MOF was found to bind promoters on 
the same set of genes in Kc cells, without any substantial enrichment towards the 
interior of X chromosomal genes, with the exception of modest binding to the roX2 
high affinity site (Supplementary Figure 15A). The presence of MSL1 could not be 
detected above threshold levels on any of the other X-chromosomal genes in Kc cells, 
in agreement with polytene chromosome stainings (data not shown). Similarly, MOF 
displayed sole promoter occupancy for an X-chromosomal gene (CG12094) and three 
autosomal genes (hbs1, frazzled (fra), gprk2) in SL-2 cells that were not found to be 
enriched by MSL1 or MSL3 (Supplementary Figure 15B). We therefore conclude that 
MOF recruitment to promoters is MSL-independent on dosage-compensated genes in 
both SL-2 and Kc cells, whereas MOF binding to the 3’ ends of these genes requires 
MSL1.
We have previously shown that sequences towards the 3 ’ end of two dosage- 
compensated genes contain targeting cues for the MSL complex (Kind and Akhtar, 
2007). We were therefore interested in testing whether MSL1 and MSL3 target the 3’ 
end of genes independently of MOF, and whether MOF localization to the gene 
interior is MSL dependent. In agreement with previous studies on polytene 
chromosomes, MSL1 binding to roX2 is only mildly affected upon MOF depletion. 
Since roX2 is a high-affinity site where partial complexes containing MSL1 can 
assemble independently of MOF and MSL3, this experiment showed consistency with 
previously published data (Kelley et al., 1999; Park et al., 2002) and confirmed the 
reproducibility between both experiments (Figure 4H). However, MSL1 binding to 
the three dosage-compensated genes or low affinity sites (Ucp4A, par-6, CG8173) is 
significantly reduced in cells depleted of MOF when compared to the EGFP RNAi 
control samples (Figure 4E-G). Therefore, we conclude that MOF is essential for
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targeting of the MSL complex to dosage-compensated genes or low-affinity binding 
sites. In contrast, binding of MSL1 to high affinity sites such as roX2 is independent 
of MOF.
Figure 4. Binding of MOF to promoters is independent of MSL1. MOF is
essential for targeting of MSL1 and MSL3 to X-linked genes, but does not 
itself require MSL1 for binding to promoters. Chromatin 
immunoprecipitation (ChIP) using MSL1 (black), MOF (red) and MSL3 
(grey) antibodies in MSL1 (A-D) or MOF-depleted (E-H) cells. Binding of 
MSL1 (black), MOF (red) and MSL3 (grey) to the X-linked genes ucp4a, 
par-6, CG8173, rox2 is shown. EGFP dsRNA-treated cells were used as
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controls. ChIP is shown as percentage recovery of input DNA. Primers were 
positioned at the promoter (P1), middle (P2) and end (P3) of genes. The exact 
position of the primers is described in supplementary text. ChIP is shown as 
percentage recovery of input DNA (% Input). Error bars represent standard 
deviation (StDev) of three independent experiments.
MOF is responsible for bulk H4K16 acetylation
Although MOF alone displays HAT activity in vitro (Akhtar and Becker, 2000) 
this has been shown to be enhanced when MOF is in complex with MSL1 and MSL3 
(Morales et al., 2004). The shift in H4K16Ac 3 ’ enrichment on the X chromosome 
(Figure, 2D), to 5 ’ enrichment on autosomes in SL-2 and Kc cells (Figure 3B) 
together with the correlation between MOF binding and H4K16Ac in both SL-2 and 
Kc cells (Figure 3D), suggests that MOF is active as a HAT on promoters 
independently of the MSL complex in vivo.
In order to test for HAT activity of MOF on promoters, we analyzed 
H4K16Ac levels for a subset of X chromosomal (CG8173, par-6, Ucp4A, roX2) and 
autosomal (hbs1, fra, gprk2) genes by ChIP-qRT-PCR analysis in cells depleted of 
MOF (Figure 5). EGFP dsRNA treated cells were used as controls. Control ChIP for 
histone H4 levels was performed in parallel for each condition. We were also eager to 
test whether the presence of MOF at promoters of X chromosomal genes in the 
absence of MSL1 is sufficient for HAT activity. As shown in Figure 5, while histone 
H4 levels remain unaffected (grey plots), we observe that H4K16Ac on the target 
genes is markedly reduced upon MOF depletion on both X chromosomal and 
autosomal targets compared to EGFP dsRNA-treated control cells (red plots). 
H4K16Ac levels in MSL1-depleted cells were reduced only on X-chromosomal 
genes, whereas in the case of autosomal MOF targets, H4K16Ac levels remained 
unaffected or showed only a slight increase. This could be due to an excess of 
available MOF protein following its apparent dissociation from the X chromosome 
(black plots). These results strongly suggest that MOF is directly involved in H4K16 
acetylation of its target genes, and that in addition, M OF’s activity on the X 
chromosome is coordinated by the other MSLs similar to the behavior observed in 
vitro (Morales et al., 2004).
These observations were further confirmed by mass spectrometric analysis of 
endogenous histones isolated from control EGFP- or MOF dsRNA-depleted SL-2 and
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Kc cells (Figure 6). MOF levels were depleted to approximately 20% of those 
observed in EGFP dsRNA-treated samples in SL-2 and Kc cells (Figure 6A). 
Interestingly, we found that at steady state only about 20% of histones were mono- 
acetylated in SL-2 cells, and approximately 15% in Kc cells. Of this monoacteylation, 
H4K16Ac was accounted for by approximately 29% and 23% of total acetylation in 
SL-2 and Kc cells, respectively. Depletion of MOF resulted in a clear reduction of 
lysine 16 acetylation, such that overall monoacetylation levels dropped to 
approximately 11% in both cell lines. In contrast, monoacetylation at H4K5 remained 
unaffected (Figure 6). Taken together, these results show that MOF is responsible for 
the bulk of H4K16 acetylation events in both SL-2 and Kc cells.
Dosage compensation acts mainly by local binding of MSL complexes
The correlation between MOF association and H4K16Ac in both SL-2 and Kc 
cells (Figure 3D, Figure 5) prompted us to test for the transcriptional regulation of 
genes by MOF in both cell types by RNAi mediated depletion followed by 
hybridization of the labeled transcript population to Affymetrix Drosophila 2 gene 
expression arrays (see Experimental Procedures). In addition, we also determined the 
expression profiles of SL-2 cells depleted of MSL1 and MSL3, in order to compare 
between regulation by MOF inside and outside the MSL context. All experiments 
were performed in triplicate and normalized against control EGFP dsRNA-treated 
samples. The three MSL proteins could be successfully depleted to a level between 
10%-20% compared to EGFP RNAi-treated cells (Supplementary Figure 16).
Overall, MOF depletion resulted in the most significant number of 
differentially expressed genes, followed by MSL3 and MSL1 in SL-2 cells (Figure 
7A-D). MSL1 depletion results in down-regulation of primarily X-chromosomal 
genes. On the X chromosome, almost all affected genes were found to be down- 
regulated (Figure 7D). Interestingly, where an MSL1 knockdown almost exclusively 
affects X-chromosomal genes, MSL3 and MOF RNAi treatment results in both up- 
and down-regulation of autosomal genes (Figure 7A-D). Genes affected by MOF and 
MSL3 could be subcategorized into various biological functions with certain 
emphasis on cell cycle related processes (Supplementary Table 4).
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Figure 5. MOF is active as a histone acetyltransferase on both the X 
chromosome and autosomes. Chromatin immunoprecipitation (ChIP) using 
histone H4 and H4K16Ac-specific antibodies on four X-linked genes ucp4a, 
par-6, CG8173, roX2, and three autosomal genes hbs1, fra and gprk2 in 
MSL1- (black) and MOF-depleted (red) cells. Histone H4 ChIP (grey) 
remained mostly unaffected in both MSL1 and MOF dsRNA-treated cells.
Primers were positioned at the promoter (P1), middle (P2) and end (P3) of 
genes. Exact position of the primers is described in supplementary text. ChIP 
is shown as percentage recovery of input DNA (% Input). Error bars 
represent standard deviation (StDev) of three independent experiments.
We next tested whether genes that were only upregulated (252 genes) or 
downregulated (217 genes) by MSL3 on autosomes were associated with a particular 
biological process. However, our analysis did not reveal a particularly intriguing 
over-represented category (Supplementary Tables 5 and 6).
The majority of genes down-regulated on the X chromosome are bound by 
either MSL1, MSL3 or MOF (Figure 7E). We confirmed this finding by ChIP with 
MOF and MSL1, followed by qRT-PCR analysis of SL-2 cells depleted of these
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proteins for 18 genes in an approximately 150kb region (see Supplementary Figure 
4). As shown in Figure 7E, genes bound by MSL1 and MOF generally show good 
correlation with differentially down-regulated genes in the cells depleted for MOF 
and MSL1 (compare upper and lower panels of Figure 7F). The minority of genes that 
are differentially expressed but not bound could be either secondary targets or genes 
distally regulated via long-range elements. We conclude that, in general, genes on the 
X chromosome that are subject to dosage compensation are directly bound by the 
MSL complex in agreement with previous studies (Alekseyenko et al., 2006; Gilfilan 
et al., 2006).
On autosomes, approximately 30% of the genes differentially regulated in 
MOF deprived cells are bound (Supplemental Figure 17). In Kc cells, we observed 
that a similar number of down-regulated genes where bound by MOF but only 15% of 
the up-regulated genes comprise real targets (Supplemental Figure 17). We verified 
gene-regulation by MOF of three target genes (hbs1, fra, gprk2) shown to display 
reduced H4K16Ac levels upon MOF depletion (Figure 5). We could confirm that for 
all three genes expression levels were reduced approxim ately tw o-fold 
(Supplementary Figure 18). Interestingly, although MSL1 depletion showed no effect 
on hbs1 and fra , expression of gprk2 was reduced similar to a MOF knockdown, 
indicating that in exceptional cases MSL1 is involved in the regulation of some genes 
on the autosomes. Taken together, these findings further support a role for MOF in 
the regulation of expression of genes on the X chromosome and a subset of autosomal 
genes.
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Total monoAc H4K16Ac H4K5Ac
Figure 6. Global levels of H4K16Ac are affected upon MOF depletion in 
both SL-2 and Kc cells. Relative quantitative analysis of acetylation of 
histone H4 sites K5/K8/K12 and K16 by mass spectrometry. (A) Western 
blot analysis of the efficiency of MOF depletion in SL-2 (right panel) and Kc 
cells (left panel). Dilution of the corresponding extracts is indicated. (B)
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Mono-acetylated peptides containing the four acetylation sites (amino acid 
(aa) 4-17) in relation to non-acetylated peptide H4 in SL-2 (B) and Kc (C) 
cells. (Columns 1, 2) Total amount of mono-acetylated peptide as fraction of 
non-acetylated peptide population; (Columns 3, 4) K16-mono-acetylated 
peptide as of fraction non-acetylated peptide population; (Columns 5, 6) K5- 
mono-acetylated non-acetylated peptide population. MOF-directed dsRNA 
interference (MOF RNAi, grey columns) in SL-2 cells leads to a reduction of 
the total fraction of mono-acetylated peptide in comparison with an unrelated 
(EGFP RNAi, black columns) control. Site-specific analysis reveals that 
H4K16-acetylation reflects loss of acetylation, while K5 acetylation remains 
unaffected. In contrast, in Kc cells overall mono-acetylation seems to be only 
slightly effected by dsRNA interference. Nevertheless, H4K16 site-specific 
mono-acetylation is reduced by a factor of 2, indicating a significant 
contribution to H4K16 acetylation by MOF-dependent activity in Kc cells.
Error bars represent standard error of mean (SEM) of at least three 
independent experiments. See also supplementary experimental procedure.
Discussion 
Differential distribution of the MSL complex members on target genes
Consistent with previous MSL1 and MSL3 profiling studies (Alekseyenko et 
al., 2006; Gilfillan et al., 2006; Legube et al., 2006), we show that MSL1, MSL3, 
MOF and H4K16Ac display enrichment to 3 ’ end of genes in SL-2 cells. 
Surprisingly, MOF displays a bimodal binding pattern on genes residing on the X 
chromosome, associating with both the 3 ’ ends of dosage compensated genes as well 
as with promoter regions.
Our recent observations on individual X chromosomal target genes using 
transgene analysis in vivo have revealed that there are at least two classes of sites; 
transcription independent “high affinity sites” such as roX2  and transcription 
dependent “low affinity sites” such as m o f  or CG3016  (Kind and Akhtar 2007). 
Integrating the observations obtained from the genome-wide binding and RNAi 
mediated knockdown analysis shown here, it appears that MOF plays a central role in 
targeting the MSL complex to “low affinity sites” where recruitment of MSL1 and 
MSL3 is found to be dependent on the presence of MOF. This is in contrast to the
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“high affinity sites’ where partial complexes of MSL1/MSL2 can be recruited 
independently of MOF, MSL3 and MLE (Dahlsveen et al., 2006).
Interestingly, we found that MOF binds not only to the male X chromosome, 
but also to autosomes and female chromosomes (Supplementary Figure 3). Different 
from the bimodal binding pattern of MOF on the male X chromosome, in Kc cells, 
MOF is enriched to promoters of all chromosomes similarly to the situation on the 
male autosomes in SL-2 cells (Figure 3B and Supplementary Figure 10). However, 
although the binding pattern between the X and the autosomes in Kc cells looks 
practically identical, the amplitude of promoter binding is significantly higher on the 
X chromosome than on the autosomes in Kc cells, as is the case in SL-2 cells 
(Supplementary Figure 13). It is possible that X chromosomal genes have as yet 
unidentified sequence elements that contribute towards MOF binding to promoters of 
X chromosomal genes in males and females. Alternatively, since reduced amount of 
MSL1 is expressed in females (Kelley et al., 1995) and MSL1 displays low level 
promoter binding on the X chromosome in SL-2 cells, it may contribute to higher 
amplitude of MOF binding on X chromosomal genes in both SL-2 and Kc cells 
compared to autosomes (Figure 2A, E, Supplementary Figure 8). As the gene density 
on the X chromosome is similar to that of other chromosomes (except for the fourth 
chromosome), this does not explain the higher amplitude of MOF binding on the X 
chromosome. It is therefore possible that MOF, in addition to its role in facilitating 
transcriptional elongation by acetylating gene loci in an MSL context, is also involved 
in transcriptional initiation in an MSL-independent manner perhaps by interaction 
with additional factors. Another interesting possibility is that the enrichment of MOF 
to promoters may provide a reservoir of enzyme, held in check by other factors, to be 
readily used by the MSL proteins or other promoter bound complexes when needed 
for modulating transcription levels.
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Figure 7. Dosage compensation acts by up-regulation of the X 
chromosome on a gene-by-gene basis. (A-C) Genome distribution of 
differentially-expressed genes in MSL1-, MSL3- and MOF-depleted SL-2 
cells. Down-regulated genes (shown as green lines) and up-regulated genes 
(shown as red lines). The white areas on the chromosomes indicate the 
position of genes. (D) Venn diagram representing overlap of up- or down-
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regulated genes on the X chromosome or autosomes. (E) Correlation between 
differential expression and MSL1, MSL3 and MOF binding on the X 
chromosome in SL-2 cells. Each major column represents genes significantly 
down-regulated in the MSL1, MSL3 and MOF RNAi depletion assays 
respectively (note that each group of columns represent different numbers of 
genes, as shown in 7D). Within each group, the proportion of genes bound by 
MSL1, MSL3 and MOF in the ChIP-chip experiments are shaded in blue 
(minor columns). Genes were sorted by hierarchical clustering within each 
group. Unbound genes are represented as white sections. Y-axis represents 
the proportion of the total number of down-regulated genes on the X 
chromosome. (F) Correlation between binding (top) and expression (bottom) 
of 18 genes on the X chromosome by qRT-PCR. MOF is depicted in red and 
MSL1 is shown in black. Error bars represent standard deviation (StDev) of 
three independent experiments for both ChIP and expression analysis. (G) 
Working model for MOF recruitment on X-linked and autosomal genes. Our 
data suggest that MOF is recruited to promoter-proximal regions 
independently of MSL1 and MSL3. In the context of the X chromosome, the 
concerted action of other complex members, such as MSL1 and MSL3, 
allows recruitment of MOF throughout gene loci, resulting in more extended 
acetylation over intragenic regions peaking towards the 3’ end. In contrast, 
on autosomes H4K16 acetylation marks are most abundant towards the 5’ 
ends of genes, directly reflecting the distribution of MOF binding sites. A 
broader distribution of MOF protein on X linked genes, together with an 
extended H6K16 acetylation, may therefore confer efficient transcriptional 
elongation. While on autosomes, 5'-end acetylation may affect a poised state 
of transcriptional potential, facilitating more effective transcription factor 
binding and/or promoting transcription initiation. H4K16Ac is represented as 
red asterisks.
Intriguingly, the MSL3 profile across gene loci appeared very similar to that 
of H4K16Ac (Figure 2A-D), suggesting a role for MSL3 in activation and/or 
stabilization of H4K16Ac on X-linked genes. In support of this hypothesis, MSL3 has 
been shown to stimulate M OF’s HAT activity in vitro (Morales et al., 2004). 
Recently, MSL3 was shown to bind H3K36 trimethylated (H3K36me3) nucleosomes 
and H3K36me3 (which also peaks at 3 ’ end of genes, similar to MSLs) was shown to 
influence MSL binding (Bell et al., 2008; Larschan et al., 2007). In S. cerevisiae Eaf3
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recognition of H3K36me3 has been shown to direct Rpd3(S) to actively transcribed 
genes to deacetylate histones in the wake of polymerase II, preventing spurious 
transcription within genes from cryptic promoters (Carrozza et al., 2005). It has been 
proposed that the MSL complex on the X chromosome may compete for the Rpd3(S) 
complex, thereby increasing the overall H4K16Ac levels by reducing the turn-over 
rates of this modification (Larschan et al., 2007).
As the 3 ’ ends of genes are indispensable for MSL target recognition on the X 
chromosome (Kind and Akhtar, 2007), we propose that MSL1 and MSL2 initially 
target 3 ’ regions by occasional recognition of degenerative DNA target elements 
(Dahlsveen et al., 2006; Gilfillan et al., 2006; Kind and Akhtar, 2007), possibly made 
accessible by low levels of H4K16Ac brought about by MOF occupancy of the 
promoter. MSL3 may serve to stabilize the association of MSL1/MSL2 with dosage 
compensated genes by binding to H3K36me3, which in turn may lead to the 
recruitment and stimulation of MOF to the body of the gene. It has also been 
proposed that local recycling of RNA polymerase II could result in enhanced mRNA 
production (Schubeler, 2006; Smith, 2001). MOF, with its enrichment to promoter­
proximal and 3’ regions, is a likely candidate to bridge such a loop formation. Gene 
structural studies should reveal whether such a gene-loop formation is involved in the 
process of dosage compensation.
MOF, H4K16 acetylation and gene regulation
Here we present four independent lines of evidence that show that MOF is 
involved in H4K16Ac of a large number of genes in the male and female genome. A: 
MOF binding significantly correlates with H4K16Ac of all chromosomes in both SL- 
2 and Kc cells (Figure 3D). B: The H4K16Ac profile across genes correlates strongly 
with the diversified binding of MOF between the X chromosome (peaking towards 
the 3 ’end of genes), and autosomes (peaking towards the 5’end of genes (compare 
Figure 2C-D with Figure 3B). C: Depletion of MOF results in a marked decrease in 
H4K16Ac of a number of genes on both the X chromosome and the autosomes 
(Figure 5). D: In MOF depleted SL-2 and Kc cells we find a more than 50% reduction 
in total H4K16Ac levels by mass specterometery analysis (Figure 6).
Several studies have implied a structural role for histone acetylation and 
H4K16Ac acetylation in particular, in the packaging of DNA into chromatin.
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Interestingly, H4K16Ac has been shown to cause an increase in the a-helical content 
of histone H4, and to prevent 30nm chromatin-fiber formation and cross-fiber 
interactions (Shogren-Knaak et al., 2006). H4K16Ac might therefore serve a 
structural role, imparting a relaxed chromatin state that, in turn, reduces the energy 
required for RNA polymerase II to affect transcription through a nucleosomal 
template and thereby enhancing elongation efficiency (Calestagne-Morelli and Ausio, 
2006).
Regulation of ubiquitously-expressed (housekeeping) genes on the X 
chromosome by the MSL complex (Legube et al., 2006; Gilfilian et al., 2006) 
probably necessitates a state of continual association with its target binding sites. 
Elevated levels of H4K16Ac are reached on the X chromosome presumably by 
constant activation of MOF by MSL1 and MSL3. On the autosomes, since MOF 
appears to be present independently of other MSL proteins, it does not associate to the 
interior of gene loci but is instead promoter bound, similar to its behavior on the X 
chromosome in the MSL1-depleted condition (Figure 4).
Assuming that MOF is involved in general transcription regulation, apart from 
dosage compensation, it is not surprising that MOF is required for most H4K16 
acetylation (Figure 6). Similarly, MOF in mammals has been found to be responsible 
for most, if not all, H4K16Ac (Smith et al., 2005; Taipale et al., 2005). Interestingly, 
in line with a possible role for MOF in the G2/M cell cycle checkpoint in mammals 
(Taipale et al., 2005) we found that in both SL-2 and Kc cells, MOF-bound targets are 
significantly enriched for certain cell-cycle functional categories (Supplementary 
Tables 1, 2 and 3). It would therefore be very interesting to study gene regulation by 
MOF in a cell-cycle context in synchronized cells.
The role of MOF mediated H4K16Ac on the autosomes remains speculative. 
H4K16Ac modification on autosomes by MOF may create an opportunity for 
transcription initiation/re-initiation, rather than being an essential mark for 
transcriptional activity itself (Anguita et al., 2001). This could also explain why we 
observe that, although MOF is generally bound to active genes (Supplementary 
Figure 14), approximately 30% of the autosomal bound genes are affected by MOF 
depletion (data not shown). M OF’s presence on autosomal genes may therefore 
provide a minimal landscape of H4K16Ac, maintaining a local environment with 
relatively open chromatin structure, presumably similar to the condition of mating
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type loci in yeast (Johnson et al., 1990; Megee et al., 1990). Upon transcriptional 
cues, those genes would be able to rapidly and efficiently respond to meet the cell's 
requirements, as would be the case for cell-cycle related genes (as discussed above).
Secondly, MOF may work together with, as yet, uncharacterized proteins 
which may allow RNA polymerase II to move efficiently through the chromatin 
template similar to the situation on the X chromosome. In fully elucidating the 
molecular mechanisms behind this process, a vital step will be the characterization of 
additional protein complexes associated with MOF, apart from the MSL complex 
(Dou et al., 2005; Mendjan et al., 2006; Smith et al., 2005). We propose that such 
complexes, comprising different trans-activating or repressive factors, may modulate 
MOF's HAT activity resulting in differential transcriptional outputs. Furthermore, 
MOF binding to promoters may allow efficient and rapid response to cellular events 
by recruitment/exclusion of H4K16 binding proteins or, more generally, by unique 
H4K16Ac-induced conformational changes to the chromatin fiber. Interestingly, one 
of the evolutionary conserved interacting partners of MOF is WDS, a protein in 
mammals shown to associate with Histone H3 lysine 4 methylation, a histone mark 
enriched at promoters (Dou et al., 2005; Han et al., 2006; Mendjan et al., 2006; 
Wysocka et al., 2005). It would be interesting to study the potential involvement of 
WDS or other promoter bound factors in recruiting MOF to promoters.
In summary, this study has revealed that the MSL complex members do not 
conform to a uniform binding behavior on their target genes on the X chromosome, 
MSL1 and MSL3 are enriched at the 3 ’ end of genes while MOF shows a bimodal 
distribution with enrichment at promoter-proximal regions as well as 3 ’ ends. Our 
data reveal that MOF plays a central role in the targeting process on low affinity sites 
where recruitment of MSL1 and MSL3 appear to be dependent on the presence of 
MOF, in contrast to high affinity sites such as roX2 where targeting of MSL1 appears 
to be MOF-independent. Furthermore, the previously unappreciated binding of MOF 
to promoter-proximal regions on X-chromosomal as well as autosomal sites provides 
an opportunity to investigate additional roles of this enzyme in other cellular 
processes.
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Experimental Procedures
Chromatin immunoprecipitation (ChIP)
All ChIP experiments were performed at least three times using independent 
chromatin preparations. The antibodies for MSL1, MSL3 and MOF are as described 
in (Mendjan et al., 2006). Anti-H4K16Ac (ab23352) and anti-Histone H4 (ab10158) 
rabbit polyclonal antibodies are from Abcam. SL-2 cells were grown in Schneider 
medium (Gibco) containing 10% FCS. 1 x 10A8 cells were cross-linked with 
formaldehyde for 8 min. Sonication was performed for 26 x 30 sec at input 5 
(Bioruptor, Diagenode) in lysis buffer (50 mM HEPES/KOH at pH 7.5, 500 mM 
NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% DOC, 0.1% SDS + Complete protease 
inhibitors (Roche)). 100_g chromatin and 3_l of polyclonal antibody was used per IP. 
Immunocomplexes were isolated by adding protein A/G-Sepharose (Roche) followed 
by four washing steps: 2x lysis buffer, 1x DOC buffer (10 mM Tris at pH 8, 0.25 M 
LiCl, 0.5% NP-40, 0.5% DOC, 1 mM EDTA), 1x TE at pH 8. DNA was eluted in 1X 
elution buffer (1%SDS, 0.1M NaHCO3) 20 min R.T. followed by reversal of 
crosslinks at 65°C O/N. DNA was purified by a 30min incubation at 37°C RNaseA 
(0.2mg/ml), followed by 2hr Proteinase K digestion (0.05mg/ml), phenol/chlororform 
exctraction and DNA precipitation. ChIP DNA samples were resuspended in 100_l 
TE. We used 1_l ChIP material for each Q-PCR reaction.
Processing and hybridization of ChIP DNA
Processing of the ChIP DNA samples for hybridization was performed according to 
(Legube et al., 2006). Hybridization, washing and scanning of arrays followed the 
Affymetrix ChIP-chip protocols.
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ChIP-chip and expression data analyses and availability
Microarray data are available in the ArrayExpress database (Parkinson et al., 2007) 
under accession numbers E-MEXP-1508 (ChIP-chip records) and E-MEXP-1505 
(gene expression records). Details on ChIP-chip and gene expression data analyses 
are available as Supplementary Experimental Procedures.
RNA interference (RNAi)
RNAi of SL-2 and Kc cells was performed as described in (Worby, 2001) with the 
following modifications. For all knockdowns cells where incubated with 45_g 
dsRNA. The cells where harvested after 4days for MSL1 RNAi and 7days for MSL3 
and MOF RNAi. For both time points, GFP control RNAi experiments where 
performed in parallel.
Quantitative real-time PCR
qRT-PCR analysis of the ChIP samples was performed using the SYBR Green PCR 
master mix (Applied Biosystem), 100 ng of each forward and reverse primer, and 1 
^ L  immunoprecipitated DNA, in an ABI7500 real-time PCR thermocycler (Applied 
Biosystems Inc.). The formula [%ChIP/input] = [£ (Ctinput-CtChip) * 100%] (where E  
represents primer annealing efficiency) was used to calculate the percentage DNA 
recovery after ChIP as compared to the amount of input material. For quantitation of 
transcript levels, RNA was first reverse-transcribed using the SuperScript RT 
(Invitrogen), and 500ng random hexamers. One microliter of cDNA was then 
subjected to real-time PCR using the SYBR Green PCR master mix (Applied 
Biosystems) and 100ng of each primer. The primers designed in the middle of the 
genes in the ChIP experiment were used for the analysis of the transcript levels.
Immuno-FISH on polytene chromosomes
Preparation of polytene chromosomes and immuno-FISH were performed as 
described
(http://www.igh.cnrs.fr/equip/cavalli/Lab%20Protocols/Immunostaining.pdf). Probes 
for FISH were generated using random-primed dioxygen-dUTP labeling (Roche) of 
the mini-white gene. Rat MSL1 antibody was used at 1:500 dilution. Images were 
captured with an AxioCamHR CCD camera on a Zeiss Axiovert200M microscope 
using a 100x PlanApochomat NA 1.4 oil immersion objective.
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Supplementary Figure legends
Supplementary Figure 1.
Processing of ChIP-chip data for MSL1. All ChIP-chip assays were performed in 
triplicates. Triplicates were averaged and normalized to 10% input DNA (For input 
DNA six replicates were used; only three are shown here for visualization purposes), 
followed by smoothening of the data by using averaging of intensities within a 500bp 
sliding window. Probes with the topmost ranked signal intensity (1%) were selected 
as significantly enriched in the ChIP sample. This metric allows for unbiased
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comparison of significant binding sites across multiple ChIP experiments where 
antibody affinities and immunoprecipitation enrichment levels differ. Profiles for 
regions of chromosomes 2L and X are illustrated. (A) GCRMA-normalized intensity 
values for individual probes across three biological replicates (light orange). (B)
Mean intensity values of the three biological replicates of MSL1 binding (orange).
(C) GCRMA-normalised intensity and mean values for the genomic DNA control 
(light and dark grey). (D) Ratios of MSL1-binding and control mean intensity signals 
(light blue). (E) Smoothed ratios using a 500-bp sliding window centred on each 
probe (dark blue). (F) Topmost ranked 1% significant ratio signal (dark blue). Flybase 
(+) and (-) represents the location of genes on the forward and reverse DNA strands 
respectively. Coordinates represent the position on the corresponding chromosome.
Supplementary Figure 2.
Same as in Supplementary Figure 1 for MOF binding on chromosomes 2R and X. (A) 
GCRMA-normalized intensity values for individual probes across three biological 
replicates (light orange). (B) Mean intensity values of the three biological replicates 
of MOF binding (orange). (C) GCRMA-normalised intensity and mean values for the 
genomic DNA control (light and dark grey). (D) Ratios of MOF-binding and control 
mean intensity signals (light blue). (E) Smoothed ratios using a 500-bp sliding 
window centred on each probe (dark blue). (F) Topmost ranked 1% significant ratio 
signal (dark blue). Flybase (+) and (-) represents the location of genes on the forward 
and reverse DNA strands respectively. Coordinates represent the position on the 
corresponding chromosome.
Supplementary Figure 3.
Proportion of MSL1, MSL3 and MOF binding, and H4K16Ac for the X chromosome 
vs. autosomes in SL-2 cells, and MOF binding and H4K16Ac in Kc cells. Bars 
represent the number of significant probes on autosomes and the X chromosome for 
each marker, divided by the total number of probes representing autosomes (dark 
blue) and the X chromosome (light blue), respectively.
Supplementary Figure 4.
(A) ChIP of a large ~150kb region on the X chromosome generated by ChIP-qRT-
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PCR and by using the significance ranking method described in Supplementary 
Figure 1. ChIP assays were performed using MSL1 and MOF antibodies, represented 
in black and blue columns, respectively. The genes used for the qRT-PCR are 
depicted in red in the ChIP-chip window. Generally three primer-pairs per gene 
represent the start, middle and end of each gene (shown as a black line, arrows 
indicate direction of transcription for each gene). For small genes, two primer-pairs 
were designed in the start and end of the genes as indicated. (B) Representation of 
binding by MSL1, MSL3 and MOF to the genes as indicated in red according to the 
ChIP-chip analysis. Flybase (+) and (-) represents the location of genes on the 
forward and reverse DNA strands respectively. Coordinates represent the position on 
the corresponding chromosome.
Supplementary Figure 5.
Distribution of MSL1, MSL3 and MOF binding across a 1.5Mb section of autosome 
2L are shown to compare with the distribution in Figure 1A. Flybase (+) and (-) 
represents location of genes on the forward and reverse DNA strands respectively. 
Coordinates represent the position on the corresponding chromosome.
Supplementary Figure 6.
Genomic distribution of MSL1 (A), MSL3 (B) and MOF (C), and H4K16Ac (D) 
binding in SL-2 cells. Similar analyses were also performed for MOF binding (E) and 
H4K16Ac (F) in Kc cells. All probes in the Drosophila tiling array were classified 
based on their mapping to the Drosophila genome (Ensembl v41; Flicek et al., 2008) 
as located in: (i) intergenic regions; (ii) the 10kb upstream the transcription start site 
of genes; (iii) genes; (iv) exons and UTRs; (v) introns; (vi) coding sequences; (vii) 
UTRs; (viii) 5 ’ UTRs; and (ix) 3 ’ UTRs. Bars represent the percentage of probes per 
class with significant binding for each factor in autosomes (dark grey) and X 
chromosome (light grey). n corresponds to the total number of significant probes per 
class for each sample.
Supplementary Figure 7.
MOF is enriched on promoters of X-linked genes on autosomes in SL-2 cells. 
Normalized binding distribution to gene loci in SL-2 cells using topmost1% targets.
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Distribution of MSL1, MSL3 and MOF binding, and H4K16Ac across autosomes (A­
D). Genes with significant binding were scaled to a similar length and the relative 
position of significant probes was computed. Bars represent number of significant 
probes in a given region. A continuous fit of the distribution is depicted in red. MOF 
binds to promoters (5’ ends) on autosomes, in addition to 3' ends of X-chromosomal 
gene loci. TSS (transcription start site) and END (transcription stop).
Supplementary Figure 8.
Individual probe intensity of MSL1, MSL3 and MOF on two X chromosomal genes, 
CG2712 (position on X: 2.588-2.591MB) and crm (position on X: 2.595-2.590MB). 
Flybase (+) and (-) represents location of genes on the forward and reverse DNA 
strands respectively. Coordinates represent position on the X chromosome.
Supplementary Figure 9.
MOF binding signal distribution across a 2kb section around the transcription start 
site (TSS) of bound genes. (A) and (C) MOF binding to X chromosomal genes in SL- 
2 cells and Kc cells respectively. (B) and (D) MOF binding to autosomal genes in SL-
2 cells and Kc cells respectively. Histograms represent the number of significant 
probes in a given region. A continuous fit of the distribution is depicted in red.
Supplementary Figure 10.
Transcription-Stop site analysis of MOF binding in SL-2 and Kc cells. MOF binding 
signal distribution across a 2kb section around the transcription stop site (TStopS) of 
bound genes. (A) MOF binding to autosomal genes in SL-2 cells. (B) MOF binding to 
X chromosomal genes in SL-2 cells. (C) MOF binding to autosomal genes in Kc cells.
(D) MOF binding to X chromosomal genes in Kc cells. Bars represent number of 
significant probes in a given region. A continuous fit of the distribution is depicted in 
red.
Supplementary Figure 11.
5 ’ to 3 ’ MOF binding signal intensity comparison on the X chromosomes and 
autosomes in SL-2 cells. Boxplots represent MOF binding intensity distribution for 
the 4kb regions centered around the transcription start site (5’ end) and transcription
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stop site (3’ end) of X chromosomal genes (A) and autosomal ones (B). The median 
intensity of the group is depicted with a solid line inside the boxes. Boxes show the 
inter-quantile range (IQR), and values 1.5 times more extreme than the IQR are 
shown individually. MOF shows a significant higher levels of binding at the 3 ’ end of 
genes on chromosome X (p < 2.2e-16). In contrast, MOF binding for autosomal genes 
is significantly stronger for the 5’ end of genes (p < 2.2e-16).
Supplementary Figure 12.
MOF binding signal distribution across a 2kb section around the transcription start 
site (TSS) of bound autosomal genes. (A) MOF binding to autosomal genes in SL-2 
cells. (B) MOF binding to autosomal genes in Kc cells. Bars represent number of 
significant probes in a given region. A continuous fit of the distribution is depicted in 
red.
Supplementary Figure 13.
5 ’ end MOF binding signal intensity comparison on the X chromosomes and 
autosomes, for SL-2 and Kc cells. Boxplots represent MOF binding intensity 
distribution for the 4kb regions centered around the transcription start site (5’ end) of 
each autosomal and X chromosomal located gene with significant binding for SL-2
(A) and Kc cells (B). The median intensity of the group is depicted with a solid line 
inside the boxes. Boxes show the inter-quantile range (IQR), and values 1.5 times 
more extreme than the IQR are plotted individually. In SL-2 cells (A) MOF displays a 
significant stronger binding in genes located in the X chromosome (p < 2e-18). (B) A 
similar trend is observed for MOF binding in Kc cells (p < 3e_08).
Supplementary Figure 14.
MOF binding and gene expression state in SL-2 and Kc cells. Genes were classified 
as being expressed (active) or inactive (absent) using the R implementation of the 
MAS5.0 algorithm available in the affy Bioconductor package. Genes called present 
in all three replicates were classified as active genes (see supplementary experimental 
procedures). (A) Overlap between active genes and MOF bound genes in SL-2 cells.
(B) Active and MOF bound genes overlap in Kc cells. (C) MOF binding overlap 
between SL-2 and Kc cells.
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(A) ChIP-qPCR using either MSL1- (black) or MOF (red) antibodies in Kc cells on 
the X chromosomal genes ucp4A, par-6, CG8173 and roX2. (B) ChIP-qPCR using 
either MSL1 (black) or MOF (red) or MSL3 (grey) antibodies in SL-2 cells on 
autosomal (hbs1, fra, gprk2) or a MOF bound X chromosomal gene CG12094. ChIP 
is shown as percentage recovery of input DNA. Primers were positioned at the start 
(P1), middle (P2) and end (P3) of genes. Exact position of the primers is described in 
supplementary text.
Supplementary Figure 16.
Western blot analyses of MSL1, MSL3 and MOF depleted SL-2 cells, as compared to 
EGFP control dsRNA treated cells. Dilution of the whole cell extract of the EGFP is 
indicated. In the case of MSL1, MSL3 and MOF RNAi, only the 100% sample of the 
three independent RNAi experiments was loaded for comparison. Antibody against a - 
tubulin was used as a loading control. Protein size markers are indicated in kDa.
Supplementary Figure 17.
MOF binding for affected genes across autosomes following MOF RNAi 
knockdowns. Each major column represents the total number of affected autosomal 
genes (up- and down-regulated) in the MOF-depleted SL-2 and Kc cells respectively. 
Blue sections correspond to MOF bound genes in each cell type. White sections 
represent genes differentially up- or down-regulated not bound by MOF. Significant 
binding was obtained using a 1% rank-based procedure restricted to autosomal 
probes. Y-axis represents the proportion of the total number of affected genes on 
autosomes.
Supplementary Figure 18.
MOF regulates expression levels of a subset of autosomal target genes. Transcript 
levels of the genes hbs1, fra  and gprk2 by qRT-PCR in SL-2 cells depleted of MSL1 
(black) and MOF (red) as compared to EGFP depleted cells. Transcript levels were 
normalized to the mitochondrial transcript mtr2.
Supplementary Figure 15.
Nuclear pore components are 
involved in the transcriptional 
regulation of dosage 
compensation in Drosophila
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A bstract
Dosage compensation in Drosophila  is dependent on MSL proteins and involves 
hypertranscription of the male X chromosome, which ensures equal X-linked gene 
expression in both sexes. Here, we report the purification of enzymatically active 
MSL complexes from Drosophila embryos, Schneider cells, and human HeLa cells. 
We find a stable association of the histone H4 lysine 16 specific acetyltransferase 
MOF with the RNA/protein containing MSL complex as well as with an evolutionary 
conserved complex. We show that the MSL complex interacts with several 
components of the nuclear pore in particular Mtor/TPR and Nup153. Strikingly, 
knockdown of Mtor or Nup153 results in loss of the typical MSL X-chromosomal 
staining and dosage compensation in Drosophila male cells but not in female cells. 
These results reveal an unexpected physical and functional connection between 
nuclear pore components and chromatin regulation through MSL proteins, 
highlighting the role of nucleoporins in gene regulation in higher eukaryotes.
Introduction
Gene expression is a highly complex process that involves several levels of 
regulation. It is a challenge to understand the interplay of these different regulation 
processes that range from chromatin remodeling and histone modifications to the 
coupling of transcription to RNA processing and export through the nuclear pore (for 
reviews see (Maniatis and Reed, 2002; Narlikar, 2002). An important, but poorly 
understood mechanism of chromatin regulation is spatial positioning in the nucleus
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and chromosomal architecture. Recent studies on the ß-globin locus and HoxB cluster 
suggest that histone modifications and chromatin condensation cannot solely account 
for transcriptional regulation, but that spatial positioning and chromosomal 
compartmentalization also play a central role in gene expression (for review see 
(Sproul et al., 2005)).
Two prominent model systems, which permit investigation of the relationship 
betw een transcrip tional activity , chrom atin structure, and chrom osom al 
compartmentalization, are the inactive female X chromosome in mammals and the 
hyperactive D rosophila  male X chromosome. Both of these model systems are 
involved in the process of dosage compensation, which ensures equalization of X- 
linked gene expression in the different sexes. It occurs in various organisms where 
sex is determ ined by heteromorphic sex chromosomes, including mammals, 
nematodes, and fruit flies. Although species use different mechanisms to achieve 
dosage compensation, a common theme is the specific alteration of the X- 
chromosome chromatin structure in one sex to modulate transcription of X-linked 
genes.
Dosage compensation in Drosophila is achieved by an approximately two-fold 
transcriptional up-regulation of X-linked genes in males. Genetic screens for male- 
specific lethality in D ro so p h ila  have identified genes essential for dosage 
compensation. The encoded proteins have been termed male-specific lethals (MSLs) 
and include MSL-1, MSL-2, MSL-3, MLE, and MOF. Together with these proteins, 
two non-coding RNAs roX1 and roX2 form the dosage compensation complex (DCC) 
(For review see (Lucchesi et al., 2005)). Another reported member of the DCC is the 
histone kinase JIL-1. Although mutation in jil-1  does not result in a male-specific 
phenotype, JIL-1 protein physically associates with the DCC and leads to enrichment 
of phosphorylation of serine 10 at histone H3 (H3S10P) on the male X (Jin et al., 
2000).
The dosage compensation complex defines the D ro so p h ila  male X 
chromosome as a specific chromatin domain with unique properties, which permits 
the subtle (2-fold) co-regulation of hundreds of genes in the course of cell 
differentiation and fly development (Sass et al., 2003). How this X-specific up- 
regulation is coordinated with gene-specific requirements remains a mystery. The 
current model posits that the DCC functions as a chromatin remodeling complex,
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which stimulates transcriptional elongation by histone H4 lysine 16 acetylation 
(Smith et al., 2001). It is likely that the mechanism of MSL function includes general 
factors involved in gene expression. These potentially essential or redundant 
components collaborating with MSLs would not be detected in a genetic screen for 
male-specific lethality in flies. We decided therefore to take a systematic, biochemical 
approach to find dosage compensation complex interactors.
In this study, we have used affinity purification with subsequent extensive 
mass-spectrometric analysis to purify and identify proteins associated with MSLs in 
flies and humans. We have isolated several new MSL-interacting proteins from fly 
embryos, Schneider SF4, and human HeLa cells. We demonstrate that there are 
evolutionary conserved MSL complexes of very similar composition in flies and 
humans. In addition, we show that MOF associates with another evolutionary 
conserved NSL complex. Surprisingly, we observed the co-purification of several 
nucleoporins in flies (including the mammalian TPR ortholog Mtor) and the co­
purification of TPR in humans. We found that Mtor and Nup153 are required for 
correct localization of MSL proteins on the X chromosome and dosage compensation 
in male but not in female cells. These results illustrate an unexpected connection 
between components of the nuclear pore complex and dosage compensation in 
Drosophila.
Results 
TAP-MOF and MSL-3FLAG proteins are functional and associate with the MSL 
complex
In order to purify the native RNA/protein-containing MSL complex, we 
generated transgenic flies expressing either TAP-tagged MOF (TAP-MOF) or FLAG- 
tagged MSL-3 (MSL-3FLAG). MSL-3FLAG was expressed in an msl-3 mutant 
background, thus eliminating any potential competition by endogenous MSL-3. The 
TAP-M OF and MSL-3FLAG transgenes rescued the male-specific lethality 
associated with m of and msl-3 mutations, and the fusion proteins localized correctly 
to the male X chromosome (Supplementary Figure S1 and data not shown). This 
demonstrates that the tagged transgenes are functional.
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Figure 1: Purification of the MOF and MSL-3 protein complexes.
A: Western blot analysis of the TAP-MOF purification for MSL proteins. All 
MSL proteins except MLE could be detected in the final eluate. NXF1 served 
as a negative control. B: Intact RNAs co-purify with both TAP-MOF and 
MSL-3FLAG in Drosophila embryos. Northern blot analysis of roX1 and 
roX2 RNAs compared with control 18S ribosomal RNA. C-E: Silver staining 
of co-purified proteins from stable TAP-MOF Schneider SF4 cells (C), TAP- 
MOF transgenic embryos (D), and MSL-3FLAG transgenic embryos (E),
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Molecular markers are indicated in kDa. Asterisks indicate degradation 
products.F: Histone H4 specific HAT activity of TAP-MOF and MSL- 
3FLAG eluates on reconstituted polynucleosomes. Autoradiograph (top 
panel) and the corresponding Coomassie gel (middle panel) of histones 
separated by SDS-PAGE are shown. Western blot analysis of a 
corresponding blot probed with H4K16Ac-specific antibody is shown in the 
bottom panel.G: Purification of the HA-2xFLAG-hMOF complex. A 
representative silver-stained gel is shown. Asterisks indicate degradation 
products. H: Confirmation of hMOF protein interactions by western blotting.
The abundant nuclear protein RCC1 was used as a control.
Nuclear extracts were prepared from transgenic and wild-type embryos. All 
purifications were performed under conditions that preserve RNA integrity. Four of 
the five MSL proteins (MSL-1, MSL-2, MSL-3 and MOF) consistently co-purified 
and eluted from the calm odulin (TAP) and FLAG beads (Figure 1A and 
Supplementary Figure S1). We opted for higher stringency during the purification to 
minimize contamination of non-specific RNAs and proteins. We did not obtain 
significant co-purification of either MLE or JIL-1. Northern blot (Figure 1B) and RT- 
PCR (Supplementary Figure S1) analyses confirmed that both roX1 and roX2 RNAs 
were enriched and intact in TAP-M OF and MSL-3FLAG affinity eluates. 
Furthermore, we did not observe any enrichment of 18S ribosomal RNA (Figure 1B) 
or U6 RNA (Supplementary Figure S1), indicating minimal contamination by these 
abundant nuclear RNAs.
In order to compare purifications between embryos and tissue culture cells, we 
also generated Drosophila SF4 cells stably expressing TAP-MOF. TAP-MOF elutes 
from SF4 nuclear extracts revealed similar co-purification of MSLs as from embryos 
(data not shown). Taken together, these data demonstrate that purifications via tagged 
MOF and MSL-3 result in consistent co-purification of MSL proteins, and that roX 
RNAs are stable components of the complex.
Mass spectrometric analysis of TAP-MOF and MSL-3FLAG purifications 
identify interacting proteins
MSL-3 and MOF-associated proteins were identified by mass spectrometry. 
MALDI-TOF, nanoelectrospray, and LC-MS/MS analyses identified a number of 
proteins that consistently co-purified with MOF and MSL-3 (Figure 1C-E). Control
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purifications performed from wild-type cells and embryos demonstrated that these 
proteins specifically interact with the tagged proteins (Figure 1C-E).
In addition to MSL proteins, we identified a number of previously 
characterized proteins in the complexes. The TAP-MOF complex contained Z4 
(Eggert et al., 2004), Chriz/Chromator (Rath et al., 2004), MBD-R2, Mtor (Zimowska 
et al., 1997), Nup153 (Sukegawa and Blobel, 1993), wds (Hollmann et al., 2002), and 
a-tubulin. Essentially the same components were purified from embryos and cells 
with two exceptions. Dis3 (Cairrao et al., 2005) and Chd1 (Stokes et al., 1996) were 
identified in embryos but not in SF4 cells, while Nup98 (Radu et al., 1995) was only 
detected in the SF4 cell purification (compare Figures 1C and 1D). Cell type specific 
interactions or varying abundances in extracts may account for the observed 
difference in the TAP-MOF associated proteins. Mass-spectrometric analysis of 
MSL-3FLAG purification identified Mtor, MBD-R2, Nup160 and Nup154, Dis3, 
Rrp6, a-tubulin and EIF-4B (Figure 1E).
A dd itio n a lly , fou r un ch arac te rized  p ro te ins (C G 1135/M C R S2, 
CG4699/NSL1, CG18041/NSL2, and CG10081/NSL3) were identified in TAP-MOF 
purifications (Table 1). We named the other new proteins NSLs (non-specific lethals), 
because disruption of these genes by P-element insertions in Drosophila is lethal in 
both sexes, in contrast to male-specific lethal genes (data not shown).
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Table 1
Drosophila Human
Name
Mascot score 
(number of peptides ) Domains
Mascot score 
(number of oeptldes) Name
MOF 1251 (34) chromo barrel MYST homology 879(57) hMOF
MSL-1 344 (14) coiled-coil, REHE 530(30) hMSL1
MSL-2 (7) RING fìnger. PHD finger 353(18) hMSL2
MSL-3 240 (24) chromo barrel, MRG homology 359(33) hMSL3
no clear orthotog N/A 2xTudor 174 (9) PHF20L1
Mtor (18) colled-col (30) TPR
Nup153 (13) zinc finger, Ran binding domain not found (Nup1 53)
Z4 156 (7) CTCF-like zinc finger N/A no clear ortholog
Chromator/Chriz 58(2) Chromodomain N/A no clear ortholog
M8D-R2 561 (18) ;h a p \  2x1 udor, M BD\ ZnF, PHD finge 155(12) PHF20
NSL1 (CG4699) 370(18) coiled-coil. PEHE 864(31) hNSL1 (KIAA1267)
NSL2 (CG18041) 98(10) two C/H rich domains 75(8) hNSL2 (FLJ20436)
NSL3 (CG9233) 244 (14) hydrolase fold 840(36) hNSL3 (FLJ 10081 )
WDS 137 (9) seven WD40 repeats 347 (35) WDR5
dMCRS2 (CG 1135) 331 (16) forehead-associated domain (FHA) 471(39) MCRS2
Dis3 (10) nucleotide-binding domain not found DIS3
(dHCF1) not found Kelch repeats, Fn3 885(18) HCF-1
(OGT) not found TPR, glycosyltransferase 174 (9) OGT
no clear ortholog N/A forkhead, FHA 130(10) ILF-1
Table 1: List of the proteins identified in TAP-MOF and HA-2xFLAG- 
hMOF purifications. Compilation of mass spectrometry data obtained using 
LC-MS/MS and MALDI-TOF from MOF complexes isolated from 
Drosophila embryos and human HeLa cells. For proteins identified by 
MALDI-TOF using peptide search tool (www.ma.nn.embl-heidelberg.de). 
only the number of peptides is indicated. :PHF20 lacks the THAP and MBD 
domains present in the Drosophila ortholog, MBD-R2.
TAP-MOF and FLAG MSL-3 eluted complexes are enzymatically active
We next examined the enzymatic activity of the purified complexes. Both 
TAP-MOF and MSL-3FLAG elutions were enriched in histone H4-specific 
acetylation activity when subjected to histone acetyltransferase assays on 
reconstituted polynucleosomes. Strikingly, the acetylation was specific for lysine
16 of histone H4 (Figure 1F), and no enrichment of histone H4 lysine 12 or histone 
H3 lysine 23 acetylation was observed (data not shown). Thus, both purifications 
resulted in elution of enzymatically active complexes.
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MOF complexes are evolutionary conserved
All Drosophila  MSL proteins have mammalian orthologs. To address the 
evolutionary conservation, we purified the human hMOF-containing complexes from 
a stable HeLa cell line expressing hMOF tagged with one haemagglutinin (HA) and 
two FLAG epitopes (HA-2xFLAG-hMOF). The characterization of the interacting 
proteins revealed striking similarities in the complex composition between flies and 
humans (Figure 1G and Table 1).
Co-purification of mammalian MSL orthologs showed that DCC is an 
evolutionary conserved protein complex. hMSL1, hMSL2, and hMSL3 were all 
present in the hMOF complex (Figure 1G and Table 1). Similar to Drosophila DCC, 
RNA helicase A (the ortholog of MLE) was not present in the complex, which is 
consistent with our previous observations (Taipale et al., 2005). Furthermore, we 
identified two isoforms of hMSL3, hMSL3a and hMSL3c, co-purifying with hMOF. 
The former represents the full-length protein, while the latter is an alternative splice 
isoform lacking the N-terminal chromo-barrel domain (Figures 1G and 1H, and data 
not shown).
In addition to the MSL proteins, most of the other proteins co-purifying with 
TAP-MOF were also found in the hMOF complex (Table 1). Z4 and Chriz/Chromator 
(Chr) lack clear mammalian orthologs, which could explain their absence (data not 
shown). However, the Mtor ortholog TPR was identified in the HA-2xFLAG-hMOF 
purification. Human-specific proteins included the transcriptional coactivator HCF-1, 
O-linked N-acetylglucosaminetransferase OGT, and the forkhead and FHA domain 
containing transcription factor ILF-1/FOXK2. Interaction of hMSL3, hNSL1, hNSL2, 
hNSL3, and HCF-1 was further confirmed by western blot analysis of eluted complex 
(Figure 1H). Similar to the TAP-MOF and MSL-3FLAG complexes, the HA- 
2xFLAG-hMOF complex specifically acetylated histone H4 at lysine 16 on 
mononucleosomes (Supplementary Figure S1).
Taken together, the data demonstrate that MOF interactions are evolutionary 
conserved, and that the DCC is an evolutionary ancient complex that acetylates 
histone H4 at lysine 16.
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MOF associates with two distinct multiprotein complexes in fruit flies and 
mammals
In this study, we have focused on the interaction of MSL proteins with Z4, 
MBD-R2, Mtor, and Nup153 in D rosophila  for which we generated specific 
antibodies. Co-immunoprecipitation experiments with MOF and MBD-R2 antibodies 
confirmed that Mtor, Nup153, Z4, Chr, and MBD-R2 interact with MOF, albeit with 
varying efficiencies (Figure 2A). The interaction of MBD-R2 with MOF was stronger 
than with Mtor or Z4 in these assays, as indicated by the amount of protein 
immunoprecipitated compared with the input.
Further immunoprecipitation experiments showed robust interactions of 
NSL1, WDS, MBD-R2, Chr, MSL-1, and MSL-3 with MOF (Figure 2B). However, 
NSL1 and MSL-1 interacted with a non-overlapping set of proteins. WDS, Chr, 
MBD-R2, and MOF co-immunoprecipitated with NSL1. MSL-1 interacted with 
MSL-3 and MOF, to a lesser extent with Chr but not with the other proteins. 
Interactions were specific, as we could not detect co-immunoprecipitation of the 
abundant nuclear proteins Mi-2 or NXF1 (Figure 2B).
To further verify the presence of two complexes, HeLa nuclear extract was 
separated on 20-50% glycerol gradient, and collected fractions were analyzed by 
western blotting (Figure 2C). While human NSL1 and NSL3 predominantly resided in 
a ~300-400 kDa complex, hMSL3 was present in a low-molecular weight complex of 
~100-200 kDa (Figure 2C). However, hMOF could be detected in both NSL and MSL 
fractions. Also HCF-1 sedimented into many fractions, which is consistent with 
previous observations (Wysocka et al., 2003).
Further analysis of NSL1 revealed that similar to MSL-1, it also contains a 
PEHE domain. MSL-1 interacts with MOF via its PEHE domain in vitro (Morales et 
al., 2004). Interestingly, we find that the PEHE domain of hNSL1 interacted directly 
with hMOF in a GST pull-down assay, whereas Drosophila ESC (extra sex combs) 
protein did not show any interaction (Figure 2D).
Our data indicate that MOF is a subunit of at least two independent protein 
complexes in Drosophila and mammals. These complexes are bifurcated, most likely, 
by a direct interaction of MSL-1 and NSL1 with MOF.
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Figure 2: MOF associates with two distinct complexes in fruit flies and 
mammals A: Immunoprecipitation from Drosophila embryo nuclear extract 
with a-MOF or a-MBD-R2 antisera. The blot was probed with various 
antibodies as indicated. B: Same as in A except immunoprecipitations were 
performed with NSL1, MOF and MSL-1 antibodies. C: 20-50% glycerol 
gradient fractionation of HeLa nuclear extract. Fractions were probed with 
antibodies against hMOF, hMSL1, hNSL1, hNSL3, and HCF-1.D: GST 
pulldown assay with PEHE domain of hNSL1 and GST only. Equal amounts 
of hMOF and dESC were used in the reaction.
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Localization of MSL proteins is unaffected in Z4 hypomorphic mutants or in 
MBD-R2 depleted cells
To examine the role of Z4 protein in dosage compensation we performed 
immunolocalisation studies on polytene chromosomes in wild type flies and 
hypomorphic mutants of Z4 protein (Eggert et al., 2004). These studies revealed that 
although Z4 and Chriz bind interbands on all chromosomes, they do not show 
extensive colocalization with M SL proteins on the male X chromosome 
(Supplementary Figure S2). In Z4 mutants, all MSL proteins remained associated 
with the X chromosome, albeit with a more diffuse staining profile (Supplementary 
Figure S2).
Since MOF and MBD-R2 robustly co-immunoprecipitate (Figure 2A), we 
next tested the effect of its depletion on the localization of MSL proteins on the male 
X chromosome in SL-2 cells. MBD-R2 protein appeared nuclear in control EGFP 
dsRNA treated cells (Supplementary Figure S2). We could deplete 90% of MBD-R2 
protein as detected by western blot analysis (Supplementary Figure S2). However, 
localization of MSL1, MSL-3 and MOF appeared unaffected in these cells 
(Supplementary Figure S2).
These results show that MOF interacts with Z4, Chriz, and MBD-R2, but 
disruption of this interaction does not affect the localization of MSL proteins on the X 
chromosome. However, these proteins may be involved in other stages of dosage 
compensation.
Mtor and Nup153 are required for the X-chromosomal localization of the MSL 
proteins.
Interestingly, the nuclear pore associated protein Mtor/TPR was identified in 
all four purifications. Mtor is proposed to be a part of the nuclear basket, interacting 
with Nup153 and is implicated in spindle matrix assembly in Drosophila (Cordes et 
al., 1998; Zimowska et al., 1997). Since Mtor mutants cause embryonic lethality in 
Drosophila (Qi et al., 2004), we used RNAi in SL-2 cells to study the function of 
Mtor and Nup153 proteins in dosage compensation. However, depletion of some 
nucleoporins can lead to defects in nucleo-cytoplasmic transport. Therefore, to 
exclude this possibility, we prepared extracts separating cytoplasmic and nuclear 
fractions. RNAi-mediated knockdown of Mtor and Nup153 depleted 90% and 70-
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80% of the proteins, respectively (Figure 3A, compare lanes 1-3 with lanes 5-7 and 9­
11). Endogenous MSL-1, MSL-2, MOF, MSL-3, MLE, and Z4 protein levels 
remained unaffected and mainly nuclear (Figure 3A, compare lanes 1-3 with 4, 5-7 
with 8, and 9-12 with 12; Supplementary Figure S3). roX2 RNA levels were reduced 
approximately two-fold, but remained nuclear (Supplementary Figure S3). roX1 RNA 
is not expressed in SL-2 cells and was therefore not included in the analysis.
In EGFP dsRNA-treated cells, immunostaining for MSL-1, MSL-3, or MOF 
visualized by confocal microscopy appears as a clear X-chromosomal territory 
staining (Figure 3B panels A-C). Mtor and Nup153 predominantly localize to the 
nuclear rim (Figure 3B, panels D-E) as visualized by co-staining with wheat germ 
agglutinin (WGA). Z4 in SL-2 cells appeared nuclear (absent from the nucleolus), 
which is consistent with it being a chromatin-interacting protein (Figure 3B, panel F, 
(Eggert et al., 2004).
In MSL-1 dsRNA treated cells, MSL-1, MSL-3, and MOF were no longer 
enriched on the X chromosome, yet localization of Mtor, Nup153, and Z4 remained 
unaffected (Supplementary Figure S3). These results are consistent with MSL-1 being 
important for the localization of other MSL proteins (Buscaino et al., 2003). 
Interestingly, cells treated with Nup153 or Mtor dsRNA displayed a phenotype 
similar to that of MSL-1 knockdown cells. The typical localization of MSL-1, MSL- 
3, and MOF on the X chromosome was compromised (Figure 3B panels G-I and 
panels M-O). In over 90% of the cells, no clear X-chromosomal staining was 
detectable. Nup153 and Mtor knockdown resulted in residual staining of the X 
chromosome with MSL-1 and MSL-3 in about 5% of cells (Figure 3B, panels G, H 
and panels M, N, see arrows). In contrast, MOF was readily detectable in the nucleus, 
yet appeared evenly dispersed in the nucleoplasm (panels I, O). Nuclear pore 
complexes were still intact as shown by nuclear rim staining with WGA (Figure 3B, 
panels J, P). Consistent with previous reports, loss of Nup153 also affected Mtor 
localization (Hase and Cordes, 2003) (Figure 3B, compare panel E with K).
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Figure 3: M tor and Nup153 knockdown in SL-2 cells causes 
delocalization of MSL proteins from the X chromosome A: SL-2 cells 
were incubated with EGFP, Mtor, or Nup153 dsRNA. 100%, 30% or 10% of 
the nuclear extracts (N) and 100% of the cytoplasmic extracts (C) were 
separated on SDS-PAGE and western blot analysis was performed. Blots
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were probed with the antibodies against Mtor, Nup153, MSL-1, MOF, MSL- 
3, Z4, and tubulin as indicated. B: Confocal microscopy was performed on 
SL-2 cells treated with EGFP, Nup153 and Mtor dsRNAs. For this purpose, 
cells were immunostained with antibodies against MSL-1 (panels a, g, m),
MSL-3 (panels b, h, n), MOF (panels c, i, o), Nup153 (panels d, j, p), Mtor 
(panels e, k, q) and Z4 (panels f, l, r). In addition, cells were also incubated 
with FITC-labeled WGA (green) to visualize the nuclear envelope (+WGA 
panel). Arrows indicate residual staining of MSL-1 and MSL-3 in Mtor 
knockdown cells in 5% of total population.
We did not observe significant changes in total MSL protein levels or a 
change in distribution between nuclear versus cytoplasmic extracts after depletion of 
Mtor or Nup153. Thus, the observed loss of typical X-chromosomal staining in Mtor 
and Nup153 depleted cells is not due to changes in MSL protein abundance or 
defective nuclear transport. However, to further address whether the loss of MSL 
localization on the X chromosome in Mtor depleted cells could be due to defects in 
general mRNA export, the intracellular distribution of bulk mRNA in Mtor cells was 
analyzed by in situ hybridization with fluorescently labeled oligo(dT) probe (Figure 
4). As previously reported, cells depleted of NXF1 showed substantial nuclear 
accumulation of poly(A)+ RNAs consistent with its essential role in RNA export 
(Herold et al., 2003). MSL-1 localization remained unaffected in NXF1 depleted 
cells. In contrast, we did not observe a significant nuclear accumulation of poly(A)+ 
RNA in Mtor depleted cells yet typical MSL staining on the X chromosome was 
compromised in these cells. (Figure 4B). This effect was specific, since depletion of 
several other nucleoporins (Nup164, Nup160, Nup98, Nup214 and Nup62) did not 
affect localization of MSL proteins on the X chromosome, although both growth and 
appearance of these cells was affected (Figure 5 and data not shown).
Taken together, our data indicate that the MSL proteins specifically require 
Nup153 and Mtor for correct localization to the male X chromosome.
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Figure 4: Mtor knockdown in SL-2 cells does not cause bulk mRNA 
accumulation in the nucleus. A: SL-2 cells were incubated with EGFP, 
Mtor, or NXF1 dsRNA. 100%, 30% or 10% of total extracts were separated 
on SDS-PAGE and western blot analysis was performed. Blots were probed 
with the antibodies against NXF1, Mtor, MSL-1 and tubulin as indicated. B:
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Confocal microscopy was performed on SL-2 cells treated with EGFP, Mtor 
or NXF1 dsRNAs. Cells were immunostained with antibodies against MSL-1 
(red) and Nup153 (green). Poly(A)+ RNA was detected by fluorescent in situ 
hybridization (FISH) using labeled oligo dT probe (yellow).
(Lucchesi et al., 2005)).
Nup153 and Mtor are required for transcriptional regulation of dosage 
compensated genes
The absence of MSL proteins in male flies leads to an approximately two-fold 
transcriptional down-regulation of dosage compensated X-linked genes (reviewed in 
Lucchesi et al., 2005). To determine whether Mtor and Nup153 are required for 
dosage compensation, we measured gene expression by quantitative RT-PCR after 
Mtor and Nup153 knockdown. We analyzed classical dosage compensated genes pgd, 
BRC  and dspt6  as well as the roX2 gene, which acts as a high affinity site for the 
dosage compensation complex on the X chromosome. The X-linked runt gene, which 
is dosage compensated in an MSL-independent manner (Smith et al., 2001), and four 
autosomal genes GAPDH, AcCoAS, E4BP, and Polli were included as controls. 
Interestingly, expression of all the X-linked genes tested was reduced approximately 
two-fold in MSL-1, Mtor, and Nup153 depleted cells in comparison to EGFP dsRNA 
treated cells (Figure 6A, compare white columns to grey and black columns). We did 
not observe significant down-regulation of runt, GAPDH, or E4BP, while AcCoAS  
expression increased slightly in MSL-1 depleted cells (light grey columns). The effect 
of Mtor and Nup153 on dosage compensation was specific, since the depletion of five 
other nucleoporins (Nup62, Nup98, Nup154, Nup160, Nup214) did not affect dosage 
compensation of X chromosomal genes (Figure 6B). Instead, we observed an 
accumulation of almost all RNAs tested suggesting a general RNA transport defect in 
Nup98, Nup154, and Nup160 depleted cells.
Finally, we tested whether Nup153 and Mtor were essential for dosage 
compensation only in male cells or whether there was a general requirement for these 
nucleoporins in female cells for X chromosomal genes. For this purpose, we 
compared the expression levels of dosage-compensated and autosomal genes in SL-2 
cells and Kc cells. We could verify that Kc cells are indeed female, as they express 
SXL, the female-specific regulator of sex determination and dosage compensation, 
but express very little MSL-2 (Figure 6C compare lanes 1-3 with lanes 7, 8). We
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could efficiently deplete Mtor and Nup153 also in Kc cells (data not shown), but we 
did not observe a significant reduction in expression of pgd, BRC, and dspt6 in these 
cells, in contrast to SL-2 cells (Figure 6D). Taken together, these results show a 
specific requirement for Mtor and Nup153 for dosage compensation of pgd, BRC, and 
dspt6 in male cells.
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Figure 5: Depletion of Nup160, Nup154, Nup98, Nup62 and 
Nup214 does not affect X chromosomal localization of MSL 
proteins A: Quantitative RT-PCR analysis of the knockdown 
efficiency of Nup160, Nup154, Nup98, Nup62 and Nup214 in two 
different experiments (1 and 2; indicated as twin columns). RNA 
concentration was measured relative to PolII transcripts in mock. 
Levels of a particular transcript in mock samples were normalized to 
100%. B: Growth curve of cells depleted for various nucleoporins as 
indicated. Cells were counted after 0, 3, 5, and 8 days after dsRNA
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treatment. C: Confocal microscopy was performed on SL-2 cells 
treated with Nup154, Nup160, Nup98, Nup62 and Nup214 dsRNA.
For this purpose cells were immunostained with either MSL-1, MSL-2, 
Nup153 or Mtor as indicated. The right panels correspond to merged 
images.
Discussion 
MOF associates with two distinct multiprotein complexes
The purification of the MSL complex revealed quite an unusual complex 
composition. One would expect that a complex thought to modulate transcription 
and/or chromatin structure would contain a significant number of classical 
transcription factors, some of the numerous components associated with RNA 
polymerase II, or at least subunits of the ubiquitous chromatin remodeling and 
modifier complexes. However, none of these components were found. Instead, there 
seems to be a core MSL complex that interacts sub-stoichiometrically with 
nucleoporins (Mtor, Nup153, Nup160, Nup98, and Nup154), interband-binding 
proteins (Z4, Chromator/Chriz), and exosome components (Rrp6, Dis3).
Our results suggest that MOF is a subunit of two independent complexes in 
mammals and fruit flies. Several lines of evidence support this notion. This includes 
co-im m unoprecipitation experim ents and glycerol gradient centrifugation. 
Furthermore, hMOF was recently found in the MLL1 methyltransferase complex 
together with HCF-1, MCRS2, WDR5, NSL1, and PHF20, but this complex did not 
contain hMSL1 (Dou et al., 2005). Finally, purification of the hMSL3 complex (data 
not shown) provides further evidence that hMSL3 does not associate with many of the 
MOF-interacting proteins. Therefore, we suggest that the NSL complex contains at 
least MOF, NSL1, NSL2, NSL3, MCRS2, MBD-R2, WDS, and in humans also HCF-
1 and OGT.
The results presented here also suggest a molecular mechanism as to how the 
MOF complexes bifurcate. Both MSL-1 and NSL1 contain a PEHE domain in their 
C-terminus. The NSL1 PEHE domain interacts directly with hMOF in vitro (Figure 
2D), and Drosophila MSL-1 has been shown to interact directly with MOF through 
the same domain (Morales et al., 2004). Furthermore, MSL-1 is required for full
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activity of MOF in vitro and for the assembly of the DCC on the male X chromosome 
(Morales et al., 2004). MSL-1 and NSL1 are the only two genes with a PEHE domain 
in the D rosophila  genome (Marin, 2003), suggesting that it is an evolutionary 
conserved MOF-interacting domain. We postulate that MSL1 and NSL1 serve as 
mutually exclusive bridging factors that assemble two different complexes around 
MOF, a histone H4 lysine 16 specific acetyltransferase.
Biochemical and functional association of nucleoporins with the dosage 
compensation complex
In the current study, we have focused on the mechanism of DCC function in 
Drosophila . All three purifications resulted in enzymatically active complexes with 
consistent co-purification of MSL-1, MSL-2, MSL-3, MOF, roX1 and roX2 but not of 
MLE or JIL-1. The absence of MLE was expected since its interaction with MSLs has 
reported to be salt and detergent sensitive (Smith et al., 2000). It is likely that JIL-1, 
like MLE, is sensitive to the purification conditions used in this study.
To examine the function of the new interacting proteins in dosage 
compensation, we studied mutant flies and used RNAi in cell culture. In Z4 mutants 
or in MBD-R2 depleted SL-2 cells, MSL localization on the X chromosome was not 
affected. Consequently, these proteins are not required for MSL recruitment or they 
have an alternative function with MOF that is independent of its role in dosage 
compensation.
However, we have discovered an unexpected link between dosage 
compensation and the nuclear pore. Depletion of either Mtor or Nup153, but not of 
other nucleoporins or NXF1 delocalized MSL proteins from the X chromosome. The 
effects observed were not due to a general transport defect, since all the five MSL 
proteins and roX2 RNA remained nuclear in Mtor and Nup153 depleted cells and we 
did not observe accumulation of bulk mRNA in these cells (Figure 3 and 4 and data 
not shown). Consistent with these observations, we show that Mtor and Nup153 are 
required for proper dosage compensation of several classical MSL-dependent dosage- 
compensated genes in SL-2 cells. The expression of these genes was not affected in 
female Kc cells.
An important question raised from our study is whether the observed effects 
are due to a soluble fraction of Mtor and Nup153 in the nucleus or due to their
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function as components of the nuclear pore complex (NPC). We favor the latter. 
Firstly, Nup153 staining is exclusively peripheral. Secondly, depletion of Nup153 
delocalizes Mtor from the nuclear periphery and increases the soluble pool of Mtor in 
the nucleoplasm (Figure 4 and (Hase and Cordes, 2003)), but MSL proteins still 
remained delocalized in Nup153 depleted cells. Finally, the fact that several 
nucleoporins, which exist together only at the nuclear pore, were co-purified with the 
MSL complexes strongly favors the idea that there is an interaction between the DCC 
and the intact NPC. This interaction is sub-stoichiometric, but with clear functional 
importance for DCC assembly or maintenance on the X chromosome.
The MSLs, higher-order chromatin structure, and nuclear periphery
A wealth of information has been generated in budding yeast regarding 
nuclear organization and gene regulation. For instance, yeast telomeres associate with 
the nuclear periphery and form a transcriptionally silenced chromatin domain 
(Feuerbach et al., 2002). However, a number of recent studies have shown that 
nuclear periphery is not just a domain of gene inactivation, but also of activation 
(Ishii et al., 2002; Schmid et al., 2004). Consistent with these observations, yeast 
MLP1 and MLP2 (Mtor orthologs in yeast) associates with transcriptionally active 
genes and are involved in re-localization of active genes to the nuclear periphery 
(Casolari et al., 2005). Furthermore, MLPs are involved in chromatin domain 
formation and pre-mRNA quality control (Sommer and Nehrbass, 2005).
Interestingly in Schneider cells, male embryos, salivary glands, and imaginal 
discs, the Drosophila male X chromosome appears localized at or near the nuclear 
periphery and in most cases even follows the nuclear rim curvature (data not shown). 
The inactive X in mammals also localizes close to the nuclear periphery as the Barr 
body. Like the Drosophila male X chromosome, the inactive X has to be globally 
controlled (inactivated) and is characterized by a special histone modification 
(trimethylation of lysine 27 of histone H3). Another common feature between 
mammals and Drosophila is that non-coding RNAs play an essential role (for review 
see (Reik and Lewis, 2005)). A possible model that can account for these intriguing 
similarities is that the nuclear periphery is used to generate transcriptional domains 
that can be transcriptionally active or inactive in order to achieve co-regulation of 
gene expression for a subset of genes (Misteli, 2005). In the case of the Drosophila
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male X chromosome, hundreds of genes with different basal transcriptional properties 
need to be co-activated by a factor of two. This kind of a subtle transcriptional co­
regulation of a whole chromosome may be achieved by partial compartmentalization 
of the X chromosome mediated by the nucleoporin-MSL interaction, allowing the 
formation of hyper-acetylated chromatin domains with unique transcriptional and/or 
posttranscriptional properties.
It is important to emphasize that Mtor and Nup153 may be required for 
general chromatin organization (not just individual chromosomes) through their 
interaction with chromatin-associated proteins. The dosage compensation complex 
might mediate X-chromosomal tethering to the nuclear pore, as a mechanism to co- 
regulate a large set of genes by creating chromosomal loops or domains. This could 
happen by direct or indirect interactions of MSLs with Mtor/Nup153 located at or 
near high affinity sites along the X chromosome, which are the binding sites of the 
dosage compensation complex. Interactions with nuclear pore components may also 
be used to “economize resources” and/or for efficient coupling of transcription to 
processing of the newly transcribed co-regulated messages. Similar models have been 
proposed previously (Blobel, 1985; Weintraub, 1985).
In summary, the purification of the MSL complex has revealed an unexpected 
link between dosage compensation and the nuclear pore complex. In the context of 
data from other systems this allows us to formulate new hypotheses about the 
mechanism of dosage compensation that will be exciting to test in the future.
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pgd BRC dspt6 E4BP GAPDH
Figure 6: Nup153 and Mtor knockdown in SL-2 cells shows down- 
regulation of X-linked gene expression. A: Quantitative PCR analysis of
pgd, BRC, dspt6, runt, GAPDH, AcCoAS and E4BP in EGFP (white), MSL-1 
(light grey), Nup153 (dark grey) and Mtor (black) dsRNA treated cells. 
Results of two independent experiments are shown as twin columns for 
example (EGFP-1 (lane 1) and EGFP-2 (lane 2). Error bars are standard 
deviations within each experiment. Expression levels were normalized 
against autosomal gene Polii and set to 100% for each gene in EGFP treated
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cells. Y-axis shows RNA levels in percentage (%). B: Quantitative PCR 
analysis of pgd, BRC, GAPDH and EF4BP in EGFP (white), Nup153 (dark 
grey), Mtor (black), Nup214 (grey), Nup62 (light grey) Nup98 (light 
blue),and Nup154 (light purple), Nup160 (dark purple) and MSL-1 (dark 
blue) dsRNA treated SL-2 cells. Error bars are standard deviations within 
each experiment. Expression levels were normalized against autosomal gene 
Polli and set to 100% for each gene in EGFP treated cells. Y-axis shows 
RNA levels in percentage (%). C: Kc cells were treated with dsRNAs 
targeting Sex-lethal (SXL) (lanes 4-6) or EGFP (lane 8) as a negative control. 
Untreated SL-2 (lanes 1-3) and Kc cells (lane 7) were incubated under mock 
RNAi conditions in parallel. Cells were collected after 7 days and 10 
micrograms of whole cell protein extracts were used for SDS-PAGE and 
immunoblotting with antibodies against MSL-2, SXL, or a-tubulin as 
indicated. D: Quantitative PCR analysis of pgd, BRC, dspt6, EF4B and 
GAPDH in EGFP (white), Nup153 (dark grey) and Mtor (black) dsRNA 
treated Drosophila Kc cells. Results of two independent experiments are 
shown as twin columns for example (EGFP-1 (lane 1) and EGFP-2 (lane 2) 
and so on). Error bars are standard deviation within each experiment. 
Expression levels were normalized against autosomal gene Polii and set to 
100% for each gene in EGFP treated cells. Y-axis shows RNA levels in 
percentage (%).
Experimental Procedures 
Transgenic flies
The coding regions of MOF and MSL-3 were fused in frame to the C-terminus of 
TAP- or N-terminus of FLAG-tag respectively in the CaSpeR-tub vector (detailed 
map available on request). 4 independent lines were tested for rescue function of the 
tub-NTAP-Mof transgene, w cv mof1/ FM7 virgins were crossed to w; tub-NTAP-Mof/ 
Balancer transgenic males and their progeny screened for presence of w cv m of/Y ; 
tub-NTAP-Mof/+  males. 2 independent lines were tested for rescue function of the 
tub-MSL-3-CFLAG transgene, virgins w; w+ msl-3-flag/CyO msl-3-FLAG; msl- 
3/msl-3 were crossed with males w; w+ msl-3-FLAG/CyO; msl-3/TM6C  and their 
progeny screened for the presence of the TM6C balancer.
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HAT assay on polynucleosomes
Polynucleosomes were prepared with recombinant Xenopus histones and incubated 
with control, TAP-MOF, MSL-3FLAG, HA-2xFLAG-hMOF extracts or eluates of 
the corresponding purifications and HAT assay performed as described previously 
(Akhtar and Becker, 2000).
Extract preparation and biochemical purification
Nuclear extracts (25 mg/ml) were prepared from Drosophila embryos (0-12hr 
collections) essentially as previously described (Varga-Weisz et al., 1997). The TAP 
purification protocol (Rigaut et al., 1999) was adapted as follows. All buffers 
contained 25 mMHepes pH 7.6 instead of Tris-HCL, KCl instead of NaCl, 1/100 
volume of RNasin (Promega), 0.2% Tween20, and 20% glycerol. FLAG purification 
was performed as above using M2-FLAG beads (Sigma). The FLAG-bound protein 
complex was eluted in elution buffer IgGEl150 (20mM Hepes pH7.6, 150mM KCl, 
5mM MgCl2, 0.5 mM EDTA, 20% glycerol and 0.4mM PMSF, 200ng/ml FLAG 
peptide, 1/100 elution volume RNAsin (Promega)).
For purification of the hMOF complex, HeLa cells were stably transfected with N- 
terminally tagged HA-2xFLAG-hMOF construct cloned in the pcDNA3.1(+) 
(Invitrogen, USA) vector. Nuclear extracts were prepared as described (Dignam et al., 
1983) and the FLAG purification performed as described above. Elution fractions 
were pooled and subjected to a-HA (Roche) immunoprecipitation. Bound proteins 
were washed with HEMG200 buffer. Before elution in SDS loading buffer, beads 
were washed briefly with TEMG200 where Hepes buffer was replaced with Tris-HCl. 
Silver staining and mass spectrometry was performed as previously described 
(Shevchenko, 1996). For GeLC-MS/MS analysis, purified protein complexes were 
separated briefly on SDS-PAGE. The gel lane was fixed, cut and subsequently 
reduced and alkylated. Proteins were digested with trypsin (Promega) and eluted with 
TFA. Peptide identification was performed using a nano-HPLC Agillent 1100 
nanoflow system connected online to a 7-Tesla linear quadrupole ion trap-Fourier 
transform (LTQ-FT) mass spectrometer (Thermo Electron, Bremen, Germany) as 
described (Olsen et al., 2004).
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Antibodies and co-immunoprecipitation assays
MSL-3, MOF, MLE antibodies were produced against full-length proteins. Fragments 
of MSL-1 (1-584 aa), Mtor (1419-1931 aa), Z4 (292-779 aa), NSL-1 (1019-1287), 
and hNSL1 (759-1105 aa) were used to immunize rats. A fragment of Nup153 (1137­
1488 aa) and MBD-R2 (90-607 aa) and hNSL3 (325-607 aa) was used to immunize 
rabbits.
For co-immunoprecipitation (IP) experiments, 80 ^l of nuclear extract (25 mg/ml) 
was used. IPs were performed in IP100-buffer (HEMG100-150, 0,5 % Tween 20, 0,2 
mg/ml BSA, 0,2 mM PMSF, 0,5 mM DTT, 1x Complete protease inhibitors tablet). 
Unless otherwise indicated extracts were incubated with 5 ^l of the respective 
antibody serum or pre-immune serum for 2 hours, rotating at 4°C.
RTPCR and Northern blot analysis
RNA was isolated from 150^l input extracts and elution fractions by extraction with 
TRIZOL (Invitrogen). RT-PCR was performed according to the manufacturer’s 
p ro to co l (In v itro g e n ) u s in g  sp e c if ic  p rim ers  fo r rox1 (P 1- 
CTATCAGTAGCAGTACACACTCTA, P2-CATCGTGCAACAATCCCAAAG), 
r o x 2  ( P 1 - C T T C A G T T T G C A T T G C G A C T T G ,  P 2 -
G C C A T C G A A A G G G T A A A T T G G ) , U 6  ( P 1 -
C T T G C T T C G G C A G A A C A T A T A C T A A A A , P 2 -
AAAAATGTGGAACGCTTCACGATT). The Northern blot analysis and FISH using 
poly d(T) probe was performed as previously described (Herold et al., 2001).
For qRT-PCR, RNA was isolated using the RNaeasy Kit (Qiagen), DNaseI treated, 
and 300-750ng of total RNA were used in a RT reaction. RT was performed as 
described above. Cytoplasmic and nuclear RNA isolation was performed as 
previously described (Herold et al., 2001). qRT-PCR was performed on a Applied 
Biosystems (AP) Cycler7500 with SYBR-detection and the amplification curves were 
analyzed with the corresponding AP-software. Each qPCR was repeated at least 4 
times, values were normalized to corresponding EGFP and p o lii values and standard 
deviation within each experiment was calculated.
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Immunofluroresence and confocal microscopy
P repara tion  of po ly tene chrom osom es was perform ed as described 
http://www.igh.cnrs.fr/equip/cavalli/Immunostaining.rtf). Apart from a-GFP antibody 
(1:50) (Torrey Pines Biolabs), a-Nup153 (1:50) and a-Chriz (1:1000) antibodies, all 
other antibodies were used at 1:500 dilution. For polytene chromosomes, images were 
captured with an AxioCamHR CCD camera on a Zeiss Axiovert200M microscope 
using a 100X PlanApochomat NA 1.4 oil immersion objective. Alternatively, images 
were taken using appropriate filter combinations with a Deltavision Spectris optical 
sectioning microscope (DeltaVision, Issaquah, USA). Images were arranged with 
Adobe Photoshop.
RNAi in SL-2 cells
RNAi in SL-2 cells were performed as described previously (Buscaino et al., 2003) 
with the following modifications. SL-2 cells were incubated with 45 ^g of MSL-1 
and harvested after 4 days. For knockdown of nucleoporins and MBD-R2 45 ^g of 
the corresponding dsRNA was added on day 1 and day 3 and cells harvested on day 9 
and 7 respectively.
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Supplementary Figure S1
A: Co-localization of MOF and MSL-3FLAG on the male X chromosome in 
transgenic larvae, visualized by immunostaining of polytene chromosomes with 
a-MSL-3 and a-MOF antibodies.
B: Localization of TAP-MOF protein to the male X chromosome. Squashes of 
polytene chromosomes were stained with a-MSL-3 and a-protein A (PAP) antibody 
to detect specifically TAP-MOF.
C: Western blot analysis of MSL proteins eluted in the MSL-3FLAG purification. I: 
Input, E: Eluate.
D: RT-PCR of roX1 and roX2 RNAs in eluates of the MSL-3FLAG purification. 
Lanes 1-4 (reactions with reverse transcriptase), lanes 5-8 (reactions without reverse 
transcriptase) U6 RNA is shown as a control.
E: RT-PCR analysis of roX1 and roX2 RNAs in eluates from TAP-MOF purification. 
Lanes 1-4 (reactions with reverse transcriptase), lanes 5-8 (reactions without reverse 
transcriptase). U6 RNA serves as a control.
F: Control immunoprecipitation (IP) experiment with a-M i2 (lane 1) or a-Pc (lane 2) 
antibodies. Following binding to beads, samples were separated by SDS-PAGE. 
Western blot analysis was performed with antibodies against the indicated proteins. 
Input represents the 5%, 1% or 0.5% (lanes 1-3) of starting extract used for IP.
G: HAT activity of HA-2xFLAG-hM OF eluates. (Top panel) Reconstituted 
mononucleosomes with wild-type H4 (wt) or tailless H4 (H4Dtail) were used as a 
substrate. (Bottom panel) western blot with specific antibodies against acetylated 
lysines. Ponceau staining verified equal loading.
Supplementary Figure S2
A: Polytene chromosomes were isolated from 3rd instar larvae from wildtype (WT) or 
Z4 hypomorphic mutants. Chromosomes were immunostained with the combination 
of either MSL-1 (red) and Chriz (green) antisera or MOF (red) and Z4 (green) 
antisera. All polytene preparations were co-stained with DAPI to visualize DNA 
(blue). Last panel also shows the merge of green and red channels.
B: SL-2 cells were incubated with EGFP or MBD-R2 dsRNA. Following protein 
knockdown, cells were harvested and nuclear (N) and cytoplasmic extracts (C) were 
prepared and separated by SDS-PAGE. Western blot analysis was performed with the
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antibodies against MBD-R2, MOF, Mtor, MSL-3 and Tubulin as indicated. The top 
two panels show short and long exposure of the MBD-R2 blot demonstrating efficient 
knockdown.
C: Confocal microscopy was performed on SL-2 cells treated with EGFP or MBD-R2 
dsRNA. For this purpose cells were immunostained with MBD-R2, Z4, MSL-1, 
MOF, Nup153 or WGA as indicated. Merge pictures are indicated in corresponding 
right panels.
Supplementary Figure S3
A: Western blot analysis of nuclear (N) versus cytoplasmic (C) extracts prepared from 
cells treated with Mtor, Nup153 or EGFP dsRNA (same experiment as in Figure 3). 
Blots were probed with antibodies generated against MLE, MSL-2, or tubulin as 
indicated.
B: RNA was isolated from nuclei or cytoplasm of corresponding cells and analyzed 
by quantitative RT-PCR for roX2, GAPDH and PolII RNA. Y-axis corresponds to 
RNA levels in percentage (%).
C: Confocal microscopy was performed on Schneider cells treated with MSL-1 
dsRNA. For this purpose cells were immunostained for MSL-1, MSL-3, MOF, 
Nup153, Mtor or Z4. In addition, all cells were incubated with WGA (green) to 
visualize the nuclear envelope (+WGA).
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Summary and General Discussion
In this thesis I have presented the work of three separate studies in which 
different approaches were chosen to study the common theme of targeting the MSL 
complex to the male X chromosome in Drosophila. All three studies highlight 
different aspects of targeting that ultimately converge in a single unified model that, 
contributes to a better understanding of not only dosage compensation but also to the 
mechanism of chromatin regulated transcriptional control.
Cotranscriptional recuitment of the MSL complex to X-linked genes based on 
exposed 3’ target sequences
In chapter 2 I have used fly genetics to study targeting of the MSL complex to 
two X-linked genes in great detail. Interestingly, one of the genes studied encodes the 
MSL complex member MOF, which is the only MSL gene, besides the genes that 
code for roxl and rox2 to reside on the X-chromosome. I found that m of and the gene 
directly upstream CG3016  are DCC target genes when inserted ectopically in an 
autosomal location by p-element mediated transformation. This finding showed, in 
addition to several other studies (Demakova et al., 2003; Fagegaltier and Baker 2004; 
Oh et al., 2004; Alekseyenko et al., 2006; Gilfilian et al., 2006) that the DCC complex 
is targeted to genes individually and therefore does not require entry sites (thereafter 
referred to as high affinity sites) for nucleation and spreading as has been proposed 
previously (Kelley et al., 1999). High affinity sites have been defined as sites that 
retain partial complexes of MSL1/MSL2 in msl3, mle and m of mutant backgrounds 
(Kelley et al., 1999). Interestingly, m of and CG3016 only constitute ectopic binding 
sites for the MSL complex when transcriptionally active, whereby the type of 
promoter is fully dispensable, showing that it is solely the act of transcription that 
reveals these genes as target sites. This observation is in agreement with three recent 
reports that show by ChIP-chip that the MSL targets preferentially active genes 
(Alekseyenko et al., 2006; Gilfilian et al., 2006; Legube et al., 2006). It is likely that 
the minority of sites that recruit the MSL complex independent of transcription are 
the high affinity sites based on two observation presented in this thesis. 1) Blocking 
transcription by means of a-amanitin results in a loss of MSL targeting to all sites 
except the previously identified high affinity sites on 19D and roX2. 2) The m of gene
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that normally does not constitute a high affinity site can be transformed into a high 
affinity site by driving its transcription from a tubulin promoter. This suggests that 
MSL targeting sequences normally embedded in chromatin, can be exposed by 
driving transcription from a very active promoter such as tubulin. Therefore, high 
affinity sites most likely do not need to be exposed to be visible as MSL target sites, 
whereas all other sites on the X chromosome need transcription in order to be 
recognized as genes “to be dosage compensated”. Therefore, the MSL complex most 
likely, is not involved in transcriptional initiation, but only associates with its targets 
while transcription is ongoing, possibly facilitating transcriptional elongation as has 
been proposed previously (Smith et al., 2001; Alekseyenko et al., 2006; Gilfillian et 
al., 2006). Consequently, the high affinity sites do not constitute dosage compensated 
genes. Their true identity and function remains a mystery to date and should be a 
primary focus in future research. In line with the observation that not all active genes 
on the X chromosome are MSL targets, is the finding that transcription of m o f and 
CG3016  alone is not sufficient for MSL recruitment. Targeting is the result of a 
combination of transcription and sequence determinants in the 3 ’end of both genes. 
Although necessary for MSL recruitment, these sequences towards the 3 ’ end on their 
own -unlike high affinity sites- are not sufficient to ectopically target the MSL 
complex, unless the signal is artificially enhanced by mulimerisation. Taken together 
the data presented in the first part of this thesis support a model of co-transcriptional 
MSL complex recruitment to genes based on exposed target sequences towards the 3 ’ 
end of genes.
MOF as a general transcriptional regulator
In chapter 3 I have utilized genome-wide transcription and binding techniques 
to gain better understanding in the general patterns that lie at the basis of dosage 
compensation and -as it turned out- general transcriptional regulation. I performed 
ChIP with antibodies raised against MSL1, MSL3 MOF, H4K16Ac and histone H4 
followed by hybridization to high-resolution genome-wide tilling arrays. In addition, 
genome-wide expression profiles were created following RNAi mediated 
knockdowns of the same proteins. Intriguingly, this study revealed that MOF, besides 
its function in dosage compensation, is also involved in general transcriptional 
regulation independently of the MSL complex.
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Surprisingly, MOF on the X chromosome displays a bimodal binding 
preference to both the 3 ’ end of dosage compensated genes as well as to promoter 
proximal regions, unlike MSL1, MSL3 and H4K16Ac which are enriched to the body 
of genes with a 3 ’ preference. Binding of MOF to promoter proximal regions is 
independent of the MSL complex, whereas binding to the body of genes is MSL1 
dependent. Although MOF is still enriched on promoter proximal regions in the 
absence of the MSL complex, its HAT activity is greatly reduced as judged by the 
diminished H4K16Ac levels on the body of X-linked genes in MSL1 depleted cells. 
Interestingly, MOFs HAT activity in vitro has been shown to be boosted in complex 
with both MSL1 and MSL3 (Morales et al., 2004). In line with this finding, the 
H4K16Ac profile across genes is basically a blueprint of the MSL3 profile suggestive 
of a role for MSL3 in activation and/or stabilization of H4K16Ac on X-linked genes 
in vivo . Taken together, these and the above-discussed data lead to a model of 
transcriptional dependent 3’ end recognition most likely by MSL1 and MSL2 
followed by translocation and activation of MOF from promoter proximal regions to 
the body of genes. MSL3 presumably has a role in modulating MOF’s HAT activity 
and might thereby create an open chromatin structure at the 3’end that facilitates the 
recognition of certain target sequences at the 3’ end of genes by MSL1 and MSL2 as 
discussed in the first section.
Surprisingly, binding of MOF to promoter proximal regions is not restricted to 
X chromosomal genes. MOF displays invariant binding to promoter proximal regions 
on autosomes and binds in female Kc cells. Unlike, the situation on the X 
chromosome however, most MOF target genes on the autosomes and in Kc cells are 
not differentially regulated in MOF depleted cells. The stable association of MSL1 
and MSL3 with X-linked genes most likely reflects the continuous expression of its 
target genes (Gilfilian et al., 2006) Similarly the lower correlation between the MOF 
bound- and affected population on autosomes could be the result of discontinuous 
expression of MOF targets on autosomes.
In this scenario, MOF would be continuously bound to promoter proximal regions 
awaiting transcriptional cues that would result in relocation of MOF to the body of 
genes for transient H4K16Ac. Alternatively, the conformation of the gene could be 
such that the gene-body is brought in contact with MOF. These premises are under 
current investigation.
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In any case, MOF is active as an HAT and is involved in transcriptional 
regulation on autosomes for the genes tested in this study. It would be of great interest 
to investigate if MOF on autosomes is similarly transactivated as is the case on the X 
chomosome. In this respect it is important to note that MOF does not only reside in 
the MSL complex but also additionally in another evolutionary conserved complex 
coined the “non specific lethal” (NSL) complex. A role for the NSL complex in MOF 
regulation is currently under investigation in our lab. The MOF complex purification 
in flies and humans was performed by Sascha Mendjan and Mikko Taipale and brings 
me to chapter four of my thesis.
A role for NUP153 and Mtor in targeting the MSL complex to the X 
chromosome
MOF associates with an unexpected set of very interesting proteins. Although, 
perhaps even more surprising was the absence of any components believed to be 
directly involved in the regulation of transcription. Therefore, the protein constitution 
of the purified MOF complex, gave little clues on what the mechanism of dosage 
compensation could be. Most proteins in the MOF complex were either poorly 
characterized or not previously studied in a transcriptional context. The only proteins 
known to associate with ongoing transcription were the exosome components Dis3 
and Rrp6, involved in mRNA surveillance (Andrulis et al., 2001). Therefore, either 
the mechanism by which MSLs exert their function was fundamentally different from 
the prevalent model, or the new MSL associates, were involved in processes they had 
so far not known to be affiliated with.
Two such proteins that I started characterizing were the nucleoporins NUP153 
and Mtor. Mtor is anchored to the nuclear pore complex (NPC) by NUP153 and both 
proteins are components of the nuclear basket (Krull et al., 2004; Hase and Cordes, 
2003). Surprisingly, in SL2 cells depleted of either of these proteins, the characteristic 
X chromosomal staining by the MSL complex was severely compromised. These 
results were neither the effect of non-specific protein or RNA leakage to the 
cytoplasm, nor a general effect attributed to a loss of NPC components. Moreover the 
expression of a number of X-linked genes was decreased approximately two-fold in 
cells depleted of either Mtor or NUP153 in male SL2 cells but not in female Kc cells, 
whereas transcript levels of an autosomal control gene and the runt gene (a MSL
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independent dosage compensated gene) remained unchanged. This report to our 
knowledge was the first and sofar the only report on transcriptional control by 
nucleoporins in higher eukaryotes.
Based on our results, Brown and Silver (Brown and Silver, 2006) proposed 
that the role for nucleoporins in regulation of dosage compensation could be to “tether 
the X chromosome to the NPC and coregulate genes by creating chromosomal loops 
or domains”. This would then in turn “create a unique domain within the nucleus that 
could recruit factors that would specifically increase expression of X-linked male 
genes” (Brown and Silver, 2006). Although it is possible that such domains are 
established, data presented in this thesis suggests that the MSL complex is targeted on 
a “gene by gene” basis and thus at least for recruitment of the MSL complex such a 
“loop formation” is not required. Also H4K16Ac does not establish large hyper- 
acetylated domains on the X chromosome as suggested by this model, but displays a 
profile that is mostly restricted to genes. Possible other factors that are required to 
confer optimal (two-fold) expression levels, only associate with X-linked genes when 
they are in association with the NPC. However, the loss of MSL staining to the X 
chromosome in Mtor or NUP153 depleted cells suggests that the role of the NUP153 
and Mtor, at least in part, is to target the MSL complex to the X chromosome.
In yeast, several nucleoporins have been implicated in the epigenetic control 
of gene expression. Presumably the most notable example is NUP2p. NUP2p can 
prevent the spread of active or inactive chromatin domains, a function known as 
boundary activity when artificially tethered between genes (Ishii et al., 2002). Such a 
role could functionally relate to the proposed NP mediated loop formation of dosage 
compensated domains (Brown and Silver, 2006). An association with the NPC might 
create domains that would restrict heterochromatin from active H4K16Ac dosage 
compensated regions or conversely, refine the MSL complex to its targets. 
Interestingly, double mutants of Mlp1 and Mlp2, the Mtor homologues in yeast, 
although not essential for boundary activity themselves, in combination with 
mutations of boundary elements are found to significantly decrease boundary activity 
(Dilworth et al., 2005). Furthermore, Mlp1 and Mlp2 have been implicated in 
telomere and mating-type loci silencing at the nuclear periphery and the organization 
of functional nuclear subcompartments (Galy et al., 2000; Feuerbach et al. 2002).
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Interestingly, by ChIP, Mlp1 has been shown to associate with distinct 
genomic elements. In addition to association with telomeres and the mating type loci, 
Mlp1 is also enriched on activate open reading frames with enrichment towards the 3 ’ 
end of genes similar to the MSL proteins (Casolari et al., 2004; Dilworth et al., 2005). 
Intriguingly, the association of Mlp1 with active genes, unlike with intergenic 
regions, is RNase sensitive (Casolari et al., 2004). Given that Mlp1 has direct links to 
mRNA export factors and is involved in transcription dependent translocation of 
genes to the nuclear periphery, these observations imply a role for Mlp in 
cotranscripional recruitment to genes followed by translocation to the nuclear 
periphery (see introduction). In this respect, it is interesting to note that NUP153 in 
mammalian cells is mobile during interphase in a transcription dependent manner 
(Griffes et al., 2004). Thus, similar to targeting of the MSL complex to X-linked 
genes, NUP153 and Mtor could be targeted to genes cotranscriptionally followed by 
translocation of these genes to the nuclear periphery, to confer optimal (two-fold) 
expression levels.
The functional interaction of nucleoporins with the MSL complex, as 
presented in this thesis, highlights the importance to put more emphasis on the spatial 
organizations of chromatin domains in specialized sub compartments within the 
nucleus. In order to establish a comprehensive three-dimensional view of chromatin 
organization, it would be of great importance to not only combine different chromatin 
binding data but also to include data that reveal the spatial organization of chromatin, 
such as chromatin conformation capture (3C) and DNA Fluorescent In Situ 
Hybridization (DNA-FISH). Combining chromatin-binding data with spatial data on 
chromatin folding and positioning, will likely dramatically change our current one­
dimensional view on chromatin into a three-dimensional highly integrated view on 
chromatin regulation of gene-expression.
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Figure 5. Two different models of NUP153 and Mtor imposed chromatin 
organization of dosage compensated domains. 1) Loop-formation of large 
structural dosage compensated domains by tethering to the nuclear periphery. 
2) Formation of dosage compensated domains by direct gene-to-gene binding 
of NUP153 and Mtor to dosage compensated genes.
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